<SEC-DOCUMENT>0001193125-23-280774.txt : 20231120
<SEC-HEADER>0001193125-23-280774.hdr.sgml : 20231120
<ACCEPTANCE-DATETIME>20231120172042
ACCESSION NUMBER:		0001193125-23-280774
CONFORMED SUBMISSION TYPE:	424B7
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20231120
DATE AS OF CHANGE:		20231120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ovintiv Inc.
		CENTRAL INDEX KEY:			0001792580
		STANDARD INDUSTRIAL CLASSIFICATION:	CRUDE PETROLEUM & NATURAL GAS [1311]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B7
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-273488
		FILM NUMBER:		231423669

	BUSINESS ADDRESS:	
		STREET 1:		370 - 17TH STREET, SUITE 1700
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202
		BUSINESS PHONE:		(303) 623-2300

	MAIL ADDRESS:	
		STREET 1:		370 - 17TH STREET, SUITE 1700
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	1847432 Alberta ULC
		DATE OF NAME CHANGE:	20191029
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B7
<SEQUENCE>1
<FILENAME>d608413d424b7.htm
<DESCRIPTION>424B7
<TEXT>
<HTML><HEAD>
<TITLE>424B7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(7)<BR> Registration Number 333-273488 </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><FONT COLOR="#ff4338"><B>The information in this preliminary prospectus supplement is not
complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where such offer or sale is not
permitted. </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>Subject to Completion
</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>Preliminary Prospectus Supplement dated November&nbsp;20, 2023 </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS SUPPLEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(To Prospectus dated
July&nbsp;27, 2023) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>8,400,000&nbsp;shares </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g608413g86o24.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>OVINTIV INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling
stockholder identified in this prospectus supplement (the &#147;<B>selling stockholder</B>&#148;) is offering 8,400,000&nbsp;shares of common stock, par value $0.01 per share (&#147;<B>common stock</B>&#148;), of Ovintiv Inc. (the
&#147;<B>Company</B>&#148;). The Company will not receive any proceeds from the sale of shares by the selling stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the
completion of this offering, we intend to purchase from the underwriter, out of the 8,400,000&nbsp;shares of our common stock that are subject of the offering, $53&nbsp;million of common stock at a price per share equal to the price per share paid
by the underwriter to the selling stockholder in this offering. Assuming a public offering price of $45.00 per share of common stock, which was the last sale price of our common stock as reported by the NYSE on November&nbsp;17, 2023, we would
repurchase 1,177,777 shares of the common stock included in this offering pursuant to the share repurchase. The closing of the offering is not conditioned upon the completion of the share repurchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The common stock is listed on the New York Stock Exchange (the &#147;<B>NYSE</B>&#148;) and on the Toronto Stock Exchange (the
&#147;<B>TSX</B>&#148;) under the symbol &#147;OVV&#148;. The last sale price of the common stock as reported by the NYSE and TSX on November&nbsp;17, 2023 was $45.00 per share and C$61.70 per share, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Investing in the common stock involves risks, including those described in the &#147;<A HREF="#suprom608413_6">Risk Factors</A>&#148;
section beginning on page S-4 of this prospectus supplement, on page 5 of the accompanying prospectus and in the documents that the Company incorporates by reference in this prospectus supplement and the accompanying prospectus. </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price&nbsp;to&nbsp;Public</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and
commissions<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to the selling
stockholder<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Total public offering price does not include the
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock sold by the selling stockholder and purchased by us from the underwriters for which no underwriting discount was paid.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See &#147;Underwriting&#148; for a description of the compensation payable to the underwriters.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes
the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock sold by the selling stockholder and purchased by us from the underwriters for which no underwriting discount was paid.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission (the &#147;SEC&#148;) nor any state securities commission has
approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter expects to deliver the shares against payment therefor on or
about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Goldman Sachs &amp; Co.
LLC </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus supplement is
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-ii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-iii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_3">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-iii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_4">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-v</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_5">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_6">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_7">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_8">DIVIDEND POLICY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_9">SELLING STOCKHOLDER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-8</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_10">U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_11">UNDERWRITING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-14</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_12">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-21</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom608413_13">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-21</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_3">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_5">OVINTIV INC.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_7">DESCRIPTION OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_8">SELLING STOCKHOLDER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_9">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_10">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_11">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering and also adds
to and updates information contained in the accompanying prospectus. The second part is the accompanying prospectus, which, among other things, gives more general information, some of which may not apply to this offering. You should read this entire
prospectus supplement as well as the accompanying prospectus and the documents incorporated by reference that are described under the &#147;Incorporation of Certain Documents by Reference&#148; section in this prospectus supplement. To the extent
that any statement in this prospectus supplement is inconsistent with statements made in the accompanying prospectus, you should rely on the information contained in this prospectus supplement, which will be deemed to modify or supersede those made
in the accompanying prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should assume that the information appearing in this prospectus supplement, the accompanying
prospectus and any free writing prospectus is accurate only as of the date on its respective cover, and that any information incorporated by reference herein or therein is accurate only as of the date of the document incorporated by reference,
unless we indicate otherwise. Our business, financial condition, results of operations and prospects may have changed since those dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither we, the selling stockholder, nor the underwriter have authorized anyone to provide you with information that is different from or
in addition to the information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus and in any related free writing prospectus that we file with the SEC. Accordingly, neither we, the selling
stockholder nor the underwriter take any responsibility for, or can provide any assurance as to the reliability of, any information that others may provide. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>This prospectus supplement and the accompanying prospectus do not constitute an offer to sell securities in any jurisdiction where such
offer or any sale is not permitted. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this prospectus supplement, except as otherwise indicated, all dollar amounts are expressed in
United States dollars, and references to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;Ovintiv,&#148; the &#147;Company,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148; refer to Ovintiv
Inc. and, where appropriate, its consolidated subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;dollars&#148;, &#147;$&#148; or &#147;US$&#148; are to United States dollars and all references to
&#147;C$&#148; are to Canadian dollars. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-ii</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_2"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed a registration statement with the SEC under the Securities Act that registers the offer and sale of the common stock covered by
this prospectus supplement. The registration statement, including the attached exhibits, contains additional relevant information about us. In addition, we file annual, quarterly and current reports, proxy statements and other information with the
SEC under the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;). The SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file
electronically with the SEC, including Ovintiv, at www.sec.gov. Ovintiv&#146;s SEC filings are also available on Ovintiv&#146;s website at www.ovintiv.com. Information on, or that is accessible from, our website, even if referred to in documents
incorporated by reference in this prospectus supplement, does not constitute part of this prospectus supplement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_3">
</A>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; information into this
prospectus supplement, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus supplement,
except for any information superseded by information contained directly in this prospectus supplement, any subsequently filed document deemed incorporated by reference or any free writing prospectus prepared by or on behalf of us. This prospectus
supplement incorporates by reference the documents set forth below that we have previously filed with the SEC (other than information deemed furnished and not filed in accordance with SEC rules, including Items 2.02 and 7.01 of Form <FONT
STYLE="white-space:nowrap">8-K).</FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1792580/000156459023002595/ovv-10k_20221231.htm">our
 Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December<U></U>&nbsp;31, 2022, filed with the SEC on February<U></U>&nbsp;27, 2023</A> (our &#147;<B>Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT></B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the information specifically incorporated by reference into <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1792580/000156459023002595/ovv-10k_20221231.htm">our
 Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT></A> from our <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1792580/000119312523077854/d386177ddef14a.htm">definitive proxy statement on Schedule
 14A, filed with the SEC on March<U></U>&nbsp;23, 2023</A>; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly periods ended <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1792580/000095017023019797/ovv-20230331.htm">March
<U></U>&nbsp;31, 2023</A>, filed with the SEC on May&nbsp;9, 2023, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000095017023035227/ovv-20230630.htm">June<U></U>&nbsp;30, 2023</A>, filed with the SEC
on July&nbsp;27, 2023 and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000095017023060397/ovv-20230930.htm">September<U></U>&nbsp;30, 2023</A>, filed with the SEC on November&nbsp;7, 2023;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1792580/000119312523089874/d444841d8k.htm">April
<U></U>&nbsp;4, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000119312523120130/d304849d8k.htm">April<U></U>&nbsp;
27, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000095017023018829/ovv-20230503.htm">May<U></U>&nbsp;
8, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000119312523143102/d280504d8k.htm">May<U></U>&nbsp;
12, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000119312523147571/d443234d8k.htm">May<U></U>&nbsp;
18, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000119312523157968/d515741d8k.htm">May<U></U>&nbsp;
31, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000119312523165428/d476002d8k.htm">June<U></U>&nbsp;12, 2023</A> (with respect to Item 1.01, 1.02, 2.01, 3.02, 8.01 and 9.01 (other than
exhibit 99.1) only), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000119312523196183/d481107d8k.htm">July<U></U>&nbsp;
27, 2023</A> (with respect to Item 8.01 only), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000119312523231926/d531863d8k.htm">September<U></U>&nbsp;
11, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000119312523234492/d554351d8k.htm">September<U></U>&nbsp;
13, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000095017023049984/ovv-20230926.htm">September<U></U>&nbsp;
26, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000095017023060392/ovv-20231107.htm">November<U></U>&nbsp;
7, 2023</A> (with respect to Item 8.01 only) and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000119312523280706/d287441d8k.htm">November&nbsp;20, 2023</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1792580/000119312520014164/d860981dex991.htm">the description of our
 capital stock contained in Exhibit 99.1 to our Current Report on Form <FONT STYLE="white-space:nowrap">8-K12B,</FONT> filed with the SEC on January<U></U>&nbsp;24, 2020, and any amendment or report filed for the purpose of updating such
description. </A> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All documents filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after
the date of this prospectus supplement and before the termination of the offering also shall be deemed to be incorporated herein by reference. We are not, however, incorporating by reference any documents or portions thereof that are not deemed
&#147;filed&#148; with the SEC, including any information furnished pursuant to Items 2.02 or 7.01 of <FONT STYLE="white-space:nowrap">Form&nbsp;8-K.</FONT> Any statements in any such future filings will automatically be deemed to modify and
supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements. Any
such statement so modified or superseded shall not be deemed to constitute a part of this prospectus supplement, except as so modified or superseded. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-iii</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will furnish without charge to you, on written or oral request, a copy of any or all of
the information that has been incorporated by reference in this prospectus supplement but not delivered with this prospectus supplement. Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by
reference into such documents. To obtain a copy of these filings at no cost, you may write or telephone us at the following address: Ovintiv Inc., 370 17th Street, Suite 1700, Denver, CO 80202, U.S.A., (303)
<FONT STYLE="white-space:nowrap">623-2300,</FONT> Attention: Corporate Secretary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-iv</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_4"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein, excluding historical
facts, contain certain forward-looking statements or information (collectively, &#147;<B>forward-looking statements</B>&#148;) within the meaning of applicable securities legislation, including Section&nbsp;27A of the Securities Act of 1933, as
amended (the &#147;<B>Securities Act</B>&#148;), and Section&nbsp;21E of the Exchange Act. All statements, except for statements of historical fact, that relate to the anticipated future activities, plans, strategies, objectives or expectations of
the Company are forward-looking statements. When used in this prospectus supplement, and the other documents incorporated herein by reference, the use of words and phrases including &#147;anticipates,&#148; &#147;believes,&#148;
&#147;continue,&#148; &#147;could,&#148; &#147;estimates,&#148; &#147;expects,&#148; &#147;focused on,&#148; &#147;forecast,&#148; &#147;guidance,&#148; &#147;intends,&#148; &#147;maintain,&#148; &#147;may,&#148; &#147;opportunities,&#148;
&#147;outlook,&#148; &#147;plans,&#148; &#147;potential,&#148; &#147;strategy,&#148; &#147;targets,&#148; &#147;will,&#148; &#147;would&#148; and other similar terminology is intended to identify forward-looking statements, although not all
forward-looking statements contain such identifying words or phrases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without limiting the generality of the foregoing, forward-looking
statements contained in this prospectus supplement and the documents incorporated herein include statements regarding: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations of plans, strategies and objectives of the Company, including anticipated reserves development;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to consummate any future acquisition and divestiture transactions;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to successfully integrate any acquired assets into its business;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">drilling plans and programs, including availability of capital to complete these plans and programs;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the composition of the Company&#146;s assets and the anticipated capital returns associated with its assets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated oil, natural gas liquids (&#147;<B>NGLs</B>&#148;) and natural gas prices; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the anticipated success of, and benefits from, technology and innovation, including the cube development model,
new or advanced drilling techniques or well completion designs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated drilling and completions activity, including the number of drilling rigs and frac crews utilized;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated proceeds and future benefits from various joint venture, partnership and other agreements;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated oil, NGLs and natural gas production and commodity mix; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s capital structure and ability to access credit facilities, credit markets and other sources of
liquidity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of the Company to timely achieve its stated environmental, social and governance goals, targets and
initiatives; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of changes in federal, state, provincial, local and tribal laws, rules and regulations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated compliance with current or proposed environmental legislation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to manage debt and financial ratios and comply with financial covenants;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the implementation and outcomes of risk management programs, including exposure to commodity prices, interest
rate and foreign exchange fluctuations and the volume of oil, NGLs and natural gas production hedged; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the declaration and payment of future dividends and the anticipated repurchase of the Company&#146;s outstanding
common shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to manage cost inflation and expected cost structures, including expected operating,
transportation, processing and labor expenses; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outlook of the oil and natural gas industry generally, including impacts from changes to the geopolitical
environment. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-v</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The forward-looking statements included in this prospectus supplement and the accompanying
prospectus and the documents incorporated herein and therein involve risks and uncertainties that could cause actual results to differ materially from projected results. Accordingly, you should not place undue reliance on forward-looking statements
as a prediction of actual results. We have based these forward-looking statements on current expectations and assumptions about future events, taking into account all information currently known by us. While we consider these expectations and
assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks and uncertainties, many of which are difficult to predict and beyond our control. The risks and uncertainties that
may affect the operations, performance and results of our business and forward-looking statements include, but are not limited to, the risk factors described in &#147;Risk Factors&#148; and additional information contained in our Annual Report on
Form <FONT STYLE="white-space:nowrap">10-K</FONT> and Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended March&nbsp;31, 2023, June&nbsp;30, 2023 and September&nbsp;30, 2023 and other risks and uncertainties
impacting our business as described from time to time in our other periodic filings with the SEC or Canadian securities regulators. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we believe the expectations represented by the forward-looking statements are reasonable based on the information available to us as
of the date such statements are made, forward-looking statements are based on our current expectations and beliefs and there can be no assurance that such expectations and beliefs will prove to be correct. All forward-looking statements contained in
this prospectus supplement and the documents incorporated herein are made as of the date of this prospectus supplement (or in the case of a document incorporated herein by reference, the date of such document) and, except as required by law, we
undertake no obligation to update publicly or revise any forward-looking statements. The forward-looking statements contained or incorporated by reference in this prospectus supplement and the documents incorporated herein are expressly qualified by
these cautionary statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read carefully the risk factors described herein and in the documents incorporated by reference
in this prospectus supplement for a description of certain risks that could, among other things, cause actual results to differ from these forward-looking statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-vi</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_5"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information more fully described elsewhere in this prospectus supplement and the accompanying prospectus.
This summary does not contain all of the information you should consider before investing in shares of common stock. You should read this prospectus supplement, the accompanying prospectus, any free writing prospectus and the documents incorporated
by reference herein and therein carefully, especially the risks of investing in shares of common stock discussed in the &#147;Risk Factors&#148; section below and in the documents incorporated by reference herein. </I></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ovintiv Inc. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ovintiv is
a leading North American oil and natural gas exploration and production company focused on developing its multi-basin portfolio of <FONT STYLE="white-space:nowrap">top-tier</FONT> oil and natural gas assets located in the United States and Canada.
Ovintiv&#146;s operations also include the marketing of oil, NGLs and natural gas. As of December&nbsp;31, 2022, all of Ovintiv&#146;s reserves and production are located in North America. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a Delaware corporation, and our principal office is located at 370 17th Street, Suite 1700, Denver, Colorado 80202, U.S.A. Our shares
of common stock are listed and posted for trading on the NYSE and the TSX under the symbol &#147;OVV&#148;. We maintain a website at www.ovintiv.com. Information on, or that is accessible from, our website, even if referred to in documents
incorporated by reference in this prospectus supplement, does not constitute part of this prospectus supplement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Share Repurchase
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to purchase from the underwriter, out of the 8,400,000&nbsp;shares of our common stock that are the subject of the
offering, $53&nbsp;million of common stock at a price per share equal to the price per share paid by the underwriter to the selling stockholder in this offering. Assuming a public offering price of $45.00 per share of common stock, which was the
last sale price of our common stock as reported by the NYSE on November&nbsp;17, 2023, we would repurchase 1,177,777 shares of the common stock included in this offering pursuant to the share repurchase. We refer to this repurchase as the
&#147;Share Repurchase.&#148; The closing of the Share Repurchase is contingent on the closing of this offering. We intend to fund the Share Repurchase with cash on hand. Any shares of our common stock that we repurchase in the Share Repurchase will
be retired. The Share Repurchase accelerates our expected future share repurchases through our existing shareholder return framework. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
closing of this offering is not conditioned upon the completion of the Share Repurchase and therefore there can be no assurance that the Share Repurchase will be completed. The description and the other information in this prospectus supplement
regarding the Share Repurchase is included in this prospectus supplement solely for informational purposes. Nothing in this prospectus supplement should be construed as an offer to sell, or the solicitation of an offer to buy, any common stock
subject to the Share Repurchase. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-1</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Offering </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Issuer </B></P></TD>
<TD>Ovintiv Inc. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Shares of common stock offered by the selling stockholder </B></P></TD>
<TD>8,400,000&nbsp;shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Shares of common stock to be outstanding immediately after this offering and the Share Repurchase
</B></P></TD>
<TD>267,309,168 shares, which reflects the retirement of $53&nbsp;million in shares of our common stock in the Share Repurchase (assuming we would repurchase 1,177,777 shares of common stock assuming a public offering price of $45.00 per share of
common stock, which was the last sale price of our common stock as reported by the NYSE on November&nbsp;17, 2023) and excludes approximately 4.4&nbsp;million shares of common stock reserved for issuance pursuant to our equity compensation plans.
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Use of proceeds </B></P></TD>
<TD>We will not receive any of the proceeds from the sale of shares of common stock by the selling stockholder. See &#147;Use of Proceeds.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Share Repurchase </B></P></TD>
<TD>Subject to completion of this offering, we intend to repurchase from the underwriter, out of the 8,400,000&nbsp;shares of our common stock that are subject of the offering, $53&nbsp;million of common stock at a price per share equal to the price
paid by the underwriter to the selling stockholder in this offering. Assuming a public offering price of $45.00 per share of common stock, which was the last sale price of our common stock as reported by the NYSE on November&nbsp;17, 2023, we would
repurchase 1,177,777 shares of the common stock included in this offering pursuant to the Share Repurchase. The closing of the offering is not conditioned upon the completion of the Share Repurchase. The closing of the Share Repurchase is contingent
on the closing of this offering. See &#147;&#151;Share Repurchase.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Dividend policy </B></P></TD>
<TD>The Company pays quarterly dividends to shareholders of its common stock at the discretion of the Board of Directors of the Company (the &#147;<B>Board of Directors</B>&#148;). On November&nbsp;7, 2023, the Board of Directors declared a
quarterly dividend of $0.30 per share of common stock payable on December&nbsp;29, 2023, to shareholders of record as of December&nbsp;15, 2023. See &#147;Dividend Policy.&#148; </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Risk factors </B></P></TD>
<TD>See &#147;Risk Factors&#148; beginning on page <FONT STYLE="white-space:nowrap">S-4</FONT> and the other information included in, or incorporated by reference into, this prospectus supplement and the accompanying prospectus for a discussion of
certain factors you should carefully consider before deciding to invest in the common stock. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-2</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>U.S. Federal Income Tax Considerations for <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders
</B></P></TD>
<TD>For a discussion of U.S. federal income tax considerations that may be relevant for <FONT STYLE="white-space:nowrap">non-U.S.</FONT> stockholders, see &#147;U.S. Federal Income Tax Considerations for
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Listing and trading symbol </B></P></TD>
<TD>The common stock is traded on the NYSE and the TSX under the symbol &#147;OVV&#148;. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Transfer agent and registrar </B></P></TD>
<TD>Odyssey Transfer US Inc. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">S-3</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_6"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Any investment in shares of common stock involves a high degree of risk. You should carefully consider the risks described below and all of
the information contained in this prospectus supplement, the accompanying prospectus, any free writing prospectus and the documents incorporated by reference herein and therein before deciding whether to purchase shares of common stock. In
particular, you should carefully consider, among other things, the risks to our business and other matters described in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form
<FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended March&nbsp;31, 2023, June&nbsp;30, 2023 and September&nbsp;30, 2023 and other filings we make with the SEC incorporated by reference into this prospectus supplement and the
accompanying prospectus. If any such risks and uncertainties actually occur, you may lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business,
financial condition or results of operations and result in a loss of all or part of your investment. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to this Offering and the Common
Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The trading price of our securities, including our common stock, is subject to volatility. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading price of our common stock may be volatile. The value of an investment in our common stock may decrease or increase abruptly, and
such volatility may bear little or no relation to our financial or operational performance. The price of our common stock may fall in response to market appraisal of our strategy or if our results of operations and/or prospects are below the
expectations of market analysts or stakeholders. In addition, equity and debt markets have, from time to time, experienced significant price and volume fluctuations that have affected the market price of securities, and may, in the future,
experience similar fluctuations which may be unrelated to our operating performance and prospects but nevertheless affect the price of our common stock. Broad equity and debt market fluctuations resulting from general economic conditions, as well as
our ability to meet or exceed market expectations, may materially and adversely affect the trading prices of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sales of a
substantial number of shares of common stock in the public markets, or the perception that such sales could occur, could reduce the market price of the common stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales of a substantial number of shares of common stock in the public market, or the perception that such sales could occur, could adversely
affect the market price of our common stock. Under the registration rights agreement, dated June&nbsp;12, 2023, between the Company and the selling stockholder, which was executed in connection with the closing of the transactions contemplated by
the purchase agreement related to our acquisition of upstream oil and gas assets located in the Permian Basin, we agreed to register the resale of 31,777,596 shares of our common stock that were issued to the selling stockholder in connection with
the transaction. Following the completion of this offering, the selling stockholder will own 8,377,596 shares of our common stock that we have registered for resale. Subject to the restrictions set forth in the following paragraph, the selling
stockholder may sell such shares in its discretion. We are unable to predict the effect that future sales by the selling stockholder or sales by other stockholders may have on the prevailing market price of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions described in the &#147;Underwriting&#148; section of this prospectus supplement, we and the selling stockholder
have agreed to enter into <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements with the underwriter of this offering pursuant to which we and they have agreed, or will agree, that we and they will not dispose of or hedge any shares of common
stock or any securities convertible into or exchangeable for shares of common stock for a period of 30 days after the date of this prospectus supplement. The underwriter may permit us or the selling stockholder to sell shares prior to the end of the
<FONT STYLE="white-space:nowrap">lock-up</FONT> period. Sales of a substantial number of such shares upon expiration of, or the perception that such sales may occur, or early release of the securities subject to, the
<FONT STYLE="white-space:nowrap">lock-up</FONT> agreements, could cause our stock price to fall or make it more difficult for you to sell common stock at a time and price that you deem appropriate. Our executive officers and our directors are not
subject to any <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements or similar restrictions in connection with this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue common stock or equity securities senior to the common stock in the future for
a number of reasons, including to finance our operations and growth plans, to adjust our ratio of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">debt-to-equity,</FONT></FONT> to satisfy our obligations upon the exercise of options
or for other reasons. Future sales or issuances of shares of common stock or other equity securities, or the availability of shares of common stock or such other equity securities for future sale or issuance, may negatively affect the trading price
of the common stock. No prediction can be made as to the effect, if any, that future sales or issuance of shares of common stock or other equity or equity-linked securities will have on the trading price of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Investors in this offering may experience future dilution. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to raise additional capital, effect acquisitions or for other purposes, we may in the future offer additional shares of common stock
or other securities convertible into, or exchangeable for, common stock at prices that may be less than the price per share of this offering. We have an effective shelf registration statement from which additional shares of common stock and other
securities can be offered. We cannot assure you that we will be able to sell shares or other securities in any other offering at a price per share that is equal to or greater than the price per share paid by investors in this offering. If the price
per share at which we sell additional shares of common stock or related securities in future transactions is less than the price per share in this offering, investors who purchase common stock in this offering will suffer a dilution of their
investment. In addition, equity awards under our share-based compensation plans may cause further dilution. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our governing documents contain
anti-takeover provisions that could delay or discourage takeover attempts that shareholders may consider favorable. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our governing
documents contain a number of provisions relating to corporate governance and to the rights of shareholders. Certain of these provisions may have a potential &#147;anti-takeover&#148; effect by delaying, deferring or preventing a change of control
of us. In addition, certain provisions of Delaware law may have a similar effect. See the &#147;Description of Common Stock&nbsp;-&nbsp;Anti-Takeover Effects of Provisions of the Certificate of Incorporation and Bylaws and Delaware Law&#148; section
in the accompanying prospectus for more information regarding these provisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_7"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not receive any proceeds from the sale of shares of common stock by the selling stockholder. The selling stockholder will receive all
of the net proceeds from the sale of these shares. See &#147;Selling Stockholder.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_8"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company pays quarterly dividends to shareholders of its common stock at the discretion of the Board of Directors. On November&nbsp;7,
2023, the Board of Directors declared a dividend of $0.30 per share of common stock totaling $82&nbsp;million payable on December&nbsp;29, 2023, to shareholders of record as of December&nbsp;15, 2023. Although we currently intend to return capital
to shareholders in the form of (a)&nbsp;a base quarterly cash dividend; (b)&nbsp;variable cash dividends; and/or (c)&nbsp;repurchases of our outstanding common stock (commonly known as share buybacks), the amount and timing of these returns of
capital to shareholders may vary from time to time. The decision whether to return capital to shareholders, as well as the timing and amount of any return of capital to shareholders, is subject to the discretion of the Board of Directors, which
regularly evaluates our proposed capital returns to shareholders and the requirements, if any, under the General Corporation Law of the State of Delaware. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_9"></A>SELLING STOCKHOLDER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder acquired the shares of common stock offered hereby in connection with our acquisition of upstream oil and gas assets
located in the Permian Basin which was completed on June&nbsp;12, 2023. On June&nbsp;12, 2023, we also entered into a registration rights agreement with the selling stockholder, pursuant to which we agreed to register the resale of 31,777,596 shares
of our common stock that were issued to the selling stockholder in connection with the transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below sets forth certain
information known to us with respect to the beneficial ownership of the shares of common stock held by the selling stockholder before and after giving effect to this offering. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of Common Stock<BR>Beneficially Owned<BR>Prior to this Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares&nbsp;of<BR>Common&nbsp;Stock<BR>Being Offered<BR>Hereby</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of Common&nbsp;Stock<BR>Beneficially Owned<BR>After Completion<BR>of&nbsp;this&nbsp;Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<SUP STYLE="font-size:75%; vertical-align:top">(1)(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NMB Stock Trust<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,777,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.15</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,377,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.08</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on 272,902,413 shares of common stock outstanding as of November&nbsp;15, 2023. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Assumes the consummation of the Share Repurchase of $53&nbsp;million of common stock at a price per share equal
to the price per share paid by the underwriter to the selling stockholder in this offering. Assuming a public offering price of $45.00&nbsp;per share of common stock, which was the last sale price of our common stock as reported by the NYSE on
November&nbsp;17, 2023, we would repurchase 1,177,777 shares of the common stock included in this offering pursuant to the share repurchase. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares of common stock held by the selling stockholder are beneficially owned by Wilmington Trust, National
Association (&#147;Wilmington&#148;), in its capacity as Administrative Trustee of the selling stockholder. Wilmington, in its fiduciary capacity as administrative trustee of the selling stockholder, is deemed to have sole voting and investment
power over such shares. The various beneficiaries of the selling stockholder have the right to receive any dividends paid with respect to the shares reported herein and to receive the proceeds from the sale of the shares reported herein.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_10"></A>U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of U.S. federal income tax considerations related to
the ownership and disposition of common stock by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder (as defined below). This summary does not purport to be a complete analysis of all potential tax considerations related thereto. This summary
is limited to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders who hold shares of common stock as capital assets within the meaning of Section&nbsp;1221 of the Internal Revenue Code of 1986, as amended (the Code), (generally, for investment
purposes). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary is based on the current provisions of the Code, final, temporary and proposed U.S. Treasury regulations
promulgated thereunder, administrative rulings and pronouncements and judicial decisions and published positions of the Internal Revenue Service (the IRS), all as in effect on the date hereof, and all of which are subject to change or differing
interpretations, possibly with retroactive effect, so as to result in U.S. federal income tax consequences different than those set forth below. We have not sought and will not seek any ruling from the IRS with respect to the statements made and the
conclusions reached in the following summary, and there can be no assurance that the IRS or a court will agree with such statements and conclusions or that a court would not sustain any challenge by the IRS in the event of litigation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary does not address all aspects of U.S. federal income taxation that may be relevant to
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders in light of their personal circumstances. In addition, this summary does not address the Medicare tax on certain investment income, U.S. federal estate or gift tax laws, any state, local or <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> tax laws or any tax treaties. This summary also does not address tax considerations applicable to investors that may be subject to special treatment under the U.S. federal income tax laws, such as: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">banks, insurance companies or other financial institutions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations or governmental organizations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">qualified foreign pension funds defined in Section&nbsp;897(l)(2) of the Code (or any entities all of the
interests of which are held by a qualified foreign pension fund); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">brokers or dealers in securities or currencies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">traders in securities that use the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> method of accounting for U.S. federal income tax purposes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons subject to the alternative minimum tax; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">partnerships, S corporations or other pass-through entities for U.S. federal income tax purposes or holders of
interests therein; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons deemed to sell common stock under the constructive sale provisions of the Code; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;controlled foreign corporations,&#148; &#147;passive foreign investment companies&#148; and corporations
that accumulate earnings to avoid U.S. federal income tax; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons that acquired common stock through the exercise of employee stock options or otherwise as compensation or
through a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">individual citizens or residents of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain former citizens or long-term residents of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">except to the limited extent discussed below, persons who actually or constructively own more than 5% of the
common stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons subject to the anti-inversion rules of Section&nbsp;7874 of the Code; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons that hold common stock as part of a straddle, appreciated financial position, synthetic security, hedge,
conversion transaction, wash sale or other integrated investment or risk reduction transaction. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS DISCUSSION IS FOR INFORMATION PURPOSES ONLY AND IS NOT INTENDED AS TAX ADVICE.
PROSPECTIVE INVESTORS ARE ENCOURAGED TO CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATION, AS WELL AS ANY TAX CONSIDERATIONS RELATING TO THE OWNERSHIP AND DISPOSITION OF
COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL, <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> OR OTHER TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder Defined </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a <FONT STYLE="white-space:nowrap">&#147;non-U.S.</FONT> holder&#148; is a beneficial owner of common stock
that is not for U.S. federal income tax purposes a partnership (or an investor therein) or any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or
organized in or under the laws of the United States, any state thereof or the District of Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust (i)&nbsp;the administration of which is subject to the primary supervision of a U.S. court and which has
one or more United States persons (within the meaning of Section&nbsp;7701(a)(30) of the Code) who have the authority to control all substantial decisions of the trust or (ii)&nbsp;which has made a valid election under applicable U.S. Treasury
regulations to be treated as a United States person. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a partnership (including an entity or arrangement treated as a
partnership for U.S. federal income tax purposes) holds common stock, the tax treatment of a partner in the partnership generally will depend upon the status of the partner, upon the activities of the partnership and the partner, and upon certain
determinations made at the partner level. Accordingly, we urge partnerships and partners in partnerships (including entities or arrangements treated as partnerships for U.S. federal income tax purposes) considering the purchase of common stock to
consult their tax advisors regarding the U.S. federal income tax considerations relating to the ownership and disposition of common stock by such partnership. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we make cash or other
property distributions on the common stock, other than certain pro rata distributions of common stock, such distributions will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and
profits, as determined under U.S. federal income tax principles. To the extent those distributions exceed our current and accumulated earnings and profits, the distributions will be treated as a <FONT STYLE="white-space:nowrap">non-taxable</FONT>
return of capital, which will reduce the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s tax basis in the common stock until such basis equals zero, and thereafter as capital gain from the sale or exchange of such common stock. See
&#147;&#151;Gain on Disposition of Common Stock.&#148; Subject to the withholding requirements applicable to the ownership of common stock of a USRPHC (as defined below), under FATCA (as defined below) and with respect to effectively connected
dividends, each of which is discussed below, any dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder on the common stock generally will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the
dividend unless an applicable income tax treaty provides for a lower rate. To receive the benefit of a reduced treaty rate, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder must generally provide the applicable withholding agent with a
properly completed and executed IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or other applicable or successor form certifying qualification
for the reduced rate. A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that does not timely furnish the required documentation, but that qualifies for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely
filing an appropriate claim for refund with the IRS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that are
effectively connected with a trade or business conducted by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in the United States (and, if required by an applicable income tax treaty, are treated as attributable to a permanent
establishment maintained by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in the United States) generally will be taxed on a net income basis at the rates and in the manner generally applicable to United States persons (as defined
under the Code). Such effectively connected dividends will not be subject to U.S. federal withholding tax if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder satisfies certain certification requirements by providing the applicable
withholding agent with a properly completed and executed IRS Form <FONT STYLE="white-space:nowrap">W-8ECI</FONT> (or other applicable or successor form) certifying eligibility for exemption. If the <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holder is a corporation for U.S. federal income tax purposes, it may also be subject to a branch profits tax at a 30% rate (or such lower rate as specified by an applicable income tax treaty) on its effectively connected earnings and profits (as
adjusted for certain items), which will include effectively connected dividends. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders
should consult their tax advisors regarding their entitlement to benefits under an applicable income tax treaty and the manner of claiming the benefits of such treaty. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain on Disposition of Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion below under &#147;&#151;Backup Withholding and Information Reporting&#148; and &#147;&#151;Additional Withholding
Requirements Under FATCA,&#148; a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will not be subject to U.S. federal income or withholding tax on any gain realized upon the sale or other taxable disposition of common stock unless:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is an individual who is present in the United States
for a period or periods aggregating 183 days or more during the calendar year in which the sale or disposition occurs and certain other conditions are met; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with a trade or business conducted by the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in the United States (and, if required by an applicable income tax treaty, is attributable to a permanent establishment maintained by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder
in the United States); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the common stock constitutes a United States real property interest by reason of our status as a
United&nbsp;States real property holding corporation (a &#147;USRPHC&#148;) for U.S. federal income tax purposes. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder described in the first bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate as specified by an applicable income tax treaty) on the amount of such gain,
which generally may be offset by U.S. source capital losses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder whose gain is
described in the second bullet point above or, subject to the exceptions described in the next paragraph, the third bullet point above, generally will be taxed on a net income basis at the rates and in the manner generally applicable to United
States persons (as defined under the Code) unless an applicable income tax treaty provides otherwise. If such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a corporation for U.S. federal income tax purposes, it may also be subject to a
branch profits tax (at a 30% rate or such lower rate specified by an applicable income tax treaty) on its effectively connected earnings and profits (as adjusted for certain items), which will include any effectively connected gain described in the
second bullet point above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, a corporation is a USRPHC if the fair market value of its United States real property interests
equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests and its other assets used or held for use in a trade or business. We believe that we currently are, and expect to remain for the foreseeable future, a
USRPHC for U.S. federal income tax purposes. However, provided that the common stock is and continues to be regularly traded on an established securities market, only a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that actually or
constructively owns, or owned at any time during the shorter of the five-year period ending on the date of the disposition or the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s holding period for the common stock, more than 5% of the
common stock will be taxed on gain realized on the taxable disposition of the common stock as a result of our status as a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
USRPHC. If the common stock were not considered to be regularly traded on an established securities market, such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder (regardless of the
percentage of stock owned) would be subject to U.S. federal income tax on a taxable disposition of the common stock (as described in the preceding paragraph), and a 15% withholding tax would apply to the gross proceeds from such disposition (and to
any distributions treated as a <FONT STYLE="white-space:nowrap">non-taxable</FONT> return of capital or capital gain from the sale or exchange of such common stock as described above under &#147;&#151;Distributions&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors with respect to the application of the foregoing
rules to their ownership and disposition of common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Backup Withholding and Information Reporting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder must be reported annually to the IRS and to the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder. Copies of these information returns may also be made available to the tax authorities in the country in which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder resides or is established.
Payments of dividends to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will not be subject to backup withholding if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder establishes an exemption by properly certifying its
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> status on an IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or other applicable or successor
form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments of the proceeds from a sale or other disposition by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of common
stock effected by or through a U.S. office of a broker generally will be subject to information reporting and backup withholding (at the applicable rate, which is currently 24%) unless the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder
establishes an exemption by properly certifying its <FONT STYLE="white-space:nowrap">non-U.S.</FONT> status on an IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> IRS Form
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or other applicable or successor form and certain other conditions are met. Information reporting and backup withholding generally will not apply to any payment
of the proceeds from a sale or other disposition of common stock effected outside the United&nbsp;States by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a broker. However, unless such broker has documentary evidence in its records
that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is not a United States person and certain other conditions are met, or the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder otherwise establishes an exemption, information
reporting will apply to a payment of the proceeds of the disposition of common stock effected outside the United States by such a broker if it has certain relationships within the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Rather, the U.S. federal income tax liability (if any) of persons subject to backup withholding
will be reduced by the amount of tax withheld. If backup withholding results in an overpayment of taxes, a refund may be obtained, provided that the required information is timely furnished to the IRS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders, including any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that actually
or constructively owns, or owned at any time during the shorter of the five-year period ending on the date of the disposition or the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s holding period for the common stock, more than 5% of
the common stock, should consult their tax advisors regarding the application of these rules to their particular circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Withholding
Requirements Under FATCA </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sections 1471 through 1474 of the Code, and the U.S. Treasury regulations and administrative guidance issued
thereunder (FATCA), impose a 30% withholding tax on any dividends paid on the common stock and (subject to the proposed U.S. Treasury regulations discussed below) on the gross proceeds from a sale or other disposition of common stock, in each case,
if paid to a &#147;foreign financial institution&#148; or a <FONT STYLE="white-space:nowrap">&#147;non-financial</FONT> foreign entity&#148; (each as defined in the Code) (including, in some cases, when such foreign financial institution or <FONT
STYLE="white-space:nowrap">non-financial</FONT> foreign entity is acting as an intermediary), unless (i)&nbsp;in the case of a foreign financial institution, such institution enters into an agreement with the U.S. government to withhold on certain
payments, and to collect and provide to the U.S. tax authorities substantial information regarding U.S. account holders of such institution (which includes certain equity and debt holders of such institution, as well as certain account holders that
are <FONT STYLE="white-space:nowrap">non-U.S.</FONT> entities with U.S. owners), (ii) in the case of a <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity, such entity certifies </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that it does not have any &#147;substantial United States owners&#148; (as defined in the Code) or provides the applicable withholding agent with a certification identifying the direct and
indirect substantial United States owners of the entity (in either case, on a properly completed and executed IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or successor form, as applicable), or
(iii)&nbsp;the foreign financial institution or <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity otherwise qualifies for an exemption from these rules and provides appropriate documentation (such as a properly completed and
executed IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or successor form, as applicable). Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the
United States governing these rules may be subject to different rules. Under certain circumstances, a holder might be eligible for refunds or credits of such taxes. Proposed U.S. Treasury regulations that may be relied upon pending adoption of final
U.S. Treasury regulations have indefinitely suspended the withholding tax on gross proceeds. Consequently, FATCA withholding is not expected to apply to gross proceeds from the sale or other disposition of common stock. <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> holders are encouraged to consult their tax advisors regarding the effects of FATCA on their investment in the common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">INVESTORS CONSIDERING THE PURCHASE OF COMMON STOCK ARE URGED TO CONSULT THEIR TAX ADVISORS REGARDING THE APPLICATION OF THE U.S. FEDERAL
INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AND THE APPLICABILITY AND EFFECT OF U.S. FEDERAL ESTATE AND GIFT TAX LAWS AND ANY STATE, LOCAL OR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> TAX LAWS AND TAX TREATIES. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_11"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms and subject to the conditions contained in an underwriting agreement dated the date of this prospectus supplement, the selling
stockholder has agreed to sell to Goldman Sachs &amp; Co. LLC, the underwriter for the offering, an aggregate of 8,400,000 shares of common stock, which includes $53&nbsp;million of our common stock that we intend to repurchase from the underwriter.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter is committed to take and pay for all of the shares of common stock offered by the selling stockholder, if any are taken.
The underwriter is offering the shares, subject to prior sale, when, as and if accepted by them, subject to approval of legal matters by their counsel, including the validity of the shares, and other conditions contained in the underwriting
agreement, such as the receipt by the underwriter of officers&#146; certificates and legal opinions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the
underwriter has agreed to purchase the shares of common stock from the selling stockholder at a price equal to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the completion of this offering, we intend to purchase from the underwriter, out of the 8,400,000&nbsp;shares of our common stock
that are subject of the offering, $53&nbsp;million of common stock at a price per share equal to the price per share paid by the underwriter to the selling stockholder in this offering. Assuming a public offering price of $45.00 per share of common
stock, which was the last sale price of our common stock as reported by the NYSE on November&nbsp;17, 2023, we would repurchase 1,177,777 shares of the common stock included in this offering pursuant to the share repurchase. The closing of the Share
Repurchase is contingent on the closing of this offering. The closing of the offering is not conditioned upon the completion of the Share Repurchase. See &#147;Summary&#151;Share Repurchase.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter initially proposes to offer the shares directly to the public at the offering price listed on the cover page of this
prospectus supplement and may offer certain of the shares to certain dealers at that price less a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. Any such
dealers may resell shares to certain other brokers or dealers at a discount of up to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share from the offering price listed on the cover page of this
prospectus supplement. After the initial offering of the shares, the underwriter may change the offering price and the other selling terms. The following table shows the underwriting discounts and commissions that the selling stockholder is to pay
to the underwriter in connection with this offering. The underwriter will not receive any underwriting discount or commission for the shares of common stock we intend to repurchase pursuant to the concurrent Share Repurchase. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and commissions paid by the selling stockholder<SUP
STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No underwriting discount or commission will be paid to the underwriter with respect to the
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock we intend to repurchase. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the offering, the underwriter may purchase and sell shares of common stock in the open market. These transactions may
include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by the underwriter of a greater number of shares than they are required to purchase in the offering, and a short
position represents the amount of such sales that have not been covered by subsequent purchase. Stabilizing transactions consist of certain bids or purchases of common stock made by the underwriter in the open market prior to the completion of the
offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These activities by the underwriter, as well as other purchases by the underwriter for its own account, may raise, stabilize,
maintain or otherwise affect the market price of the common stock. As a result, the price of the common stock may be higher than the price that otherwise might exist in the open market. If these activities are commenced, they may be discontinued by
the underwriter at any time. These transactions may be effected in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or otherwise. Neither we nor the underwriter makes any representation or
prediction as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to the direction or magnitude of any effect that the transactions described above may have on the price of the common stock. In addition, neither we nor the underwriter makes any representation
that the underwriter will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate that our share of the total expenses of the offering will be approximately $0.5&nbsp;million. We have agreed to pay certain
expenses, excluding underwriting discounts and commissions, incurred by the selling stockholder in connection with this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and
the selling stockholder have agreed to indemnify the underwriter and any of its affiliates against certain liabilities, including liabilities under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter and its affiliates are full service financial institutions engaged in various activities, which may include sales and trading,
commercial and investment banking, advisory, investment management, investment research, principal investment, hedging, market making, brokerage and other financial and <FONT STYLE="white-space:nowrap">non-financial</FONT> activities and services.
The underwriter and certain of its affiliates have provided, and may in the future provide, a variety of these services to the Company and to persons and entities with relationships with the Company, for which they received or will receive customary
fees and expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of their various business activities, the underwriter and its affiliates, officers, directors
and employees may purchase, sell or hold a broad array of investments and actively trade securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments for their own account and for the accounts of
their customers, and such investment and trading activities may involve or relate to assets, securities and/or instruments of the Company (directly, as collateral securing other obligations or otherwise) and/or persons and entities with
relationships with the Company. The underwriter and its affiliates may also communicate independent investment recommendations, market color or trading ideas and/or publish or express independent research views in respect of such assets, securities
or instruments and may at any time hold, or recommend to clients that they should acquire, long and/or short positions in such assets, securities and instruments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter and certain of its affiliates are arrangers, lenders, dealers or agents under certain of our debt facilities, including the
Company&#146;s term loan facility and the Company&#146;s revolving credit facilities and derivative instruments. If the underwriter or its respective affiliates have lending relationships with us, certain of the underwriter or its respective
affiliates routinely hedge their credit exposure to us consistent with their customary risk management policies. Typically, the underwriter and its respective affiliates would hedge such exposure by entering into transactions, which may consist of
either the purchase of credit default swaps or the creation of short positions in our securities, including potentially the shares offered hereby. Any such credit default swaps or short positions could adversely affect future trading prices of the
shares offered hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the period beginning from the date of this prospectus supplement and continuing to and including 30 days
after the closing of this offering, we agree not to offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise transfer or dispose of, directly or indirectly, any securities of ours that are substantially
similar to the shares, or publicly disclose the intention to make any offer, sale, pledge, disposition or filing, without the prior written consent of the underwriter. Our executive officers and our directors are not subject to any <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements or similar restrictions in connection with this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder
has entered into lock-up agreements with the underwriter prior to the commencement of this offering pursuant to which each of these persons, subject to certain limited exceptions, will not, during the period ending 30 days after the date of this
prospectus supplement, without the prior written consent of the underwriter, (i) offer, sell, contract to sell, pledge, grant any option to purchase, lend or otherwise dispose of any shares of common stock or any options or warrants to purchase any
shares of common stock or any securities convertible into, exchangeable for or that represent the right to receive shares of common stock (such options, warrants or other securities, collectively, &#147;Derivative Instruments&#148;), including
without limitation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any such shares or Derivative Instruments now owned or hereafter acquired by the signatory of the lock-up agreements, (ii) engage in any hedging or other transaction or arrangement (including,
without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) which is designed to or
which reasonably could be expected to lead to or result in a sale, loan, pledge or other disposition (whether by the signatory of the lock-up agreements or someone other than such signatory), or transfer of any of the economic consequences of
ownership, in whole or in part, directly or indirectly, of any shares of common stock or Derivative Instruments, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of common stock or
other securities, in cash or otherwise or (iii) otherwise publicly announce any intention to engage in or cause any action or activity described in clause (i) above or transaction or arrangement described in clause (ii) above. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selling Restrictions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European Economic Area
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made
available to any retail investor in the European Economic Area (&#147;EEA&#148;). For these purposes, a retail investor means a person who is one (or more) of: (i)&nbsp;a retail client as defined in point (11)&nbsp;of Article 4(1) of Directive
2014/65/EU (as amended, &#147;MiFID II&#148;); or (ii)&nbsp;a customer within the meaning of Directive (EU) 2016/97, as amended, where that customer would not qualify as a professional client as defined in point (10)&nbsp;of Article 4(1) of MiFID
II; or (iii)&nbsp;not a qualified investor as defined in Regulation (EU) 2017/1129 (as amended, the &#147;Prospectus Regulation&#148;). Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the &#147;PRIIPs
Regulation&#148;) for offering or selling the shares or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the shares or otherwise making them available to any retail investor in the
EEA may be unlawful under the PRIIPs Regulation. This prospectus supplement has been prepared on the basis that any offer of shares in any member state of the EEA will be made pursuant to an exemption under the Prospectus Regulation from the
requirement to publish a prospectus for offers of shares. This prospectus supplement is not a prospectus for the purposes of the Prospectus Regulation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>United Kingdom </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares are not
intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom (&#147;UK&#148;). For these purposes, a retail investor means a person who is one
(or more) of: (i)&nbsp;a retail client, as defined in point (8)&nbsp;of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (&#147;EUWA&#148;); (ii) a customer within the
meaning of the provisions of the Financial Services and Markets Act 2000 (as amended, &#147;FSMA&#148;) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional
client, as defined in point (8)&nbsp;of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA; or (iii)&nbsp;not a qualified investor as defined in Article 2 of Regulation (EU) 2017/1129 as it forms part
of domestic law by virtue of the EUWA (the &#147;UK Prospectus Regulation&#148;). Consequently, no key information document required by the PRIIPs Regulation as it forms part of domestic law by virtue of the EUWA (the &#147;UK PRIIPs
Regulation&#148;) for offering or selling the shares or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the shares or otherwise making them available to any retail investor in the UK
may be unlawful under the UK PRIIPs Regulation. This prospectus supplement has been prepared on the basis that any offer of shares in the UK will be made pursuant to an exemption under the UK Prospectus Regulation from the requirement to publish a
prospectus for offers of shares. This prospectus supplement is not a prospectus for the purposes of the UK Prospectus Regulation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter has represented and agreed that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it has only communicated or caused to be communicated and will only communicate or cause to be communicated an
invitation or inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the FSMA) received by it in connection with the issue or sale of the shares which are the subject of the offering contemplated by this prospectus
supplement and the accompanying prospectus in circumstances in which Section&nbsp;21(1) of the FSMA does not apply to the Company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it
in relation to the shares in, from or otherwise involving the United Kingdom. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Canada </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter may offer the shares in Canada to &#147;permitted clients&#148; within the meaning of National Instrument <FONT
STYLE="white-space:nowrap">31-103</FONT> Registration Requirements, Exemptions and Ongoing Registrant Obligations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Switzerland </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus is not intended to constitute an offer or solicitation to purchase or invest in the
shares. The shares may not be publicly offered, directly or indirectly, in Switzerland within the meaning of the Swiss Financial Services Act (&#147;FinSA&#148;) and no application has or will be made to admit the shares to trading on any trading
venue (exchange or multilateral trading facility) in Switzerland. Neither this prospectus supplement, the accompanying prospectus nor any other offering or marketing material relating to the shares constitutes a prospectus pursuant to the FinSA, and
neither this prospectus supplement, the accompanying prospectus nor any other offering or marketing material relating to the shares may be publicly distributed or otherwise made publicly available in Switzerland. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In particular, this prospectus supplement will not be filed with, and the offer of the shares will not be supervised by, the Swiss Financial
Market Supervisory Authority, and the offer of the shares has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (the &#147;CISA&#148;). The investor protection afforded to acquirers of interests in
collective investment schemes under the CISA does not extend to acquirers of the shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dubai International Financial Centre </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority
(&#147;DFSA&#148;). This prospectus supplement is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no
responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus supplement nor taken steps to verify the information set forth herein and has no responsibility for the prospectus
supplement. The shares to which this prospectus supplement relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the shares offered should conduct their own due diligence on the shares. If you do not
understand the contents of this prospectus supplement you should consult an authorized financial advisor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Hong Kong </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter has represented and agreed that it has not offered or sold and will not offer or sell the shares in Hong Kong by means of any
document other than to &#147;professional investors&#148; within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder, or other than in circumstances which do not constitute an offer to the
public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32, Laws of Hong Kong) or which do not result in the document being a &#147;prospectus&#148; within the meaning of the Companies (Winding Up and
Miscellaneous Provisions) Ordinance (Cap.&nbsp;32, Laws of Hong Kong); and that it has not and will not issue and has not and will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not have in its possession for the purpose of issue any advertisement, invitation or document relating to the shares (in each case whether in Hong Kong or elsewhere) which is directed at, or the
contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to persons
outside Hong Kong or only to &#147;professional investors&#148; within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Japan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter has
represented and agreed that the shares have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No.&nbsp;25 of 1948, as amended), which we refer to as the Financial Instruments and Exchange Law, and has
agreed not to offer or sell the shares, directly or indirectly, in Japan or to, or for the account or benefit of, any Japanese Person or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or
to, or for the account or benefit of, any Japanese Person, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Law and any other applicable laws, regulations
and ministerial guidelines of Japan. For the purposes of this paragraph &#147;Japanese Person&#148; means any person resident in Japan, including any corporation or other entity organized under the laws of Japan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Singapore </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus
supplement and the accompanying prospectus have not been and will not be registered as a prospectus under the Securities and Futures Act, Chapter 289 of Singapore (the &#147;SFA&#148;) by the Monetary Authority of Singapore and the offer of the
shares in Singapore is made primarily pursuant to the exemption under Sections 274 and 275 of the SFA. Accordingly, this prospectus supplement, the accompanying prospectus and any other document or material in connection with the offer or sale, or
invitation for subscription or purchase, of the shares may not be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to any person
in Singapore other than (a)&nbsp;to an institutional investor as defined in Section&nbsp;4A of SFA (an &#147;Institutional Investor&#148;) pursuant to Section&nbsp;274 of the SFA, (b)&nbsp;to an accredited investor as defined in Section&nbsp;4A of
the SFA (an &#147;Accredited Investor&#148;) or other relevant person as defined in Section&nbsp;275(2) of the SFA (a &#147;Relevant Person&#148;) and pursuant to Section&nbsp;275(1) of the SFA, or to any person pursuant to an offer referred to in
Section&nbsp;275 (1A) of the SFA, and in accordance with the conditions specified in Section&nbsp;275 of the SFA, or (c)&nbsp;otherwise pursuant to, and in accordance with, the conditions of any other applicable exemption or provision of the SFA.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is a condition of the offer that where the shares are subscribed for or acquired pursuant to an offer made in reliance on
Section&nbsp;275 of the SFA by a Relevant Person which is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a corporation (which is not an Accredited Investor), the sole business of which is to hold investments and the
entire share capital of which is owned by one or more individuals, each of whom is an Accredited Investor; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor, securities or securities-based derivatives contracts (each as defined in Section&nbsp;2(1) of the SFA) of that corporation and the beneficiaries&#146; rights and interest
(howsoever defined) in that trust shall not be transferred within six months after that corporation or that trust has subscribed for or acquired the shares except: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to an Institutional Investor, and Accredited Investor or other Relevant Person, or which arises from an offer
referred to in Section&nbsp;275(1A) of the SFA (in the case of that corporation) or Section&nbsp;276(4)(i)(B) of the SFA (in the case of that trust); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(y)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where no consideration is or will be given for the transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(z)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where the transfer is by operation of law; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(aa)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Section&nbsp;276(7) of the SFA; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(bb)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and
Securities-based Derivatives Contracts) Regulations 2018 of Singapore. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notification under Section&nbsp;309B(1)(c) of
the SFA&#151;Solely for the purposes of its obligations pursuant to Sections 309B(1)(a) and 309B(1)(c) of the SFA, the Company has determined, and hereby notifies all relevant persons (as defined in Section&nbsp;309A of the SFA) that the shares are
&#147;prescribed capital markets products&#148; (as defined in the Securities and Futures (Capital Markets Products) Regulations 2018) and &#147;Excluded Investment Products&#148; (as defined in MAS Notice SFA
<FONT STYLE="white-space:nowrap">04-N12:</FONT> Notice on the Sale of Investment Products and MAS Notice <FONT STYLE="white-space:nowrap">FAA-N16:</FONT> Notice on Recommendations on Investment Products). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Taiwan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares have not been
and will not be registered with the Financial Supervisory Commission of Taiwan, the Republic of China (&#147;Taiwan&#148;), pursuant to relevant securities laws and regulations and may not be offered or sold in Taiwan through a public offering or in
any manner which could constitute an offer within the meaning of the Securities and Exchange Act of Taiwan or would otherwise require registration with or the approval of the Financial Supervisory Commission of Taiwan. No person or entity in Taiwan
has been authorized to offer, sell, give advice regarding or otherwise intermediate the offering or sale of the shares in Taiwan. The shares may be made available to Taiwan resident investors outside Taiwan for purchase by such investors outside
Taiwan for purchase outside Taiwan by investors residing in Taiwan, but may not be issued, offered, sold or resold in Taiwan, unless otherwise permitted by Taiwan laws and regulations. No subscription or other offer to purchase the shares shall be
binding on us until received and accepted by us or any underwriter outside of Taiwan (the &#147;Place of Acceptance&#148;), and the purchase/sale contract arising therefrom shall be deemed a contract entered into in the Place of Acceptance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Korea </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares have not been
and will not be registered with the Financial Services Commission of Korea under the Financial Investment Services and Capital Markets Act of Korea. Accordingly, the shares have not been and will not be offered, sold or delivered, directly or
indirectly, in Korea or to, or for the account or benefit of, any resident of Korea (as defined in the Foreign Exchange Transactions Law of Korea and its Enforcement Decree) or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or
resale, except as otherwise permitted by applicable Korean laws and regulations. In addition, within one year following the issuance of the shares, the shares may not be transferred to any resident of Korea other than a qualified institutional buyer
(as such term is defined in the regulation on issuance, public disclosure, etc. of securities of Korea, a &#147;Korean QIB&#148;) registered with the Korea Financial Investment Association (the &#147;KOFIA&#148;) as a Korean QIB and subject to the
requirement of monthly reports with the KOFIA of its holding of Korean QIB bonds as defined in the Regulation on Issuance, Public Disclosure, etc. of shares of Korea; provided that (a)&nbsp;the shares are denominated, and the principal and interest
payments thereunder are made, in a currency other than Korean won, (b)&nbsp;the amount of the securities acquired by such Korean QIBs in the primary market is limited to less than 20&nbsp;percent of the aggregate issue amount of the shares,
(c)&nbsp;the shares are listed on one of the major overseas securities markets designated by the Financial Supervisory Service of Korea, or certain procedures, such as registration or report with a foreign financial investment regulator, have been
completed for offering of the securities in a major overseas securities market, (d)&nbsp;the one year restriction on offering, delivering or selling of securities to a Korean resident other than a Korean QIB is expressly stated in the securities,
the relevant underwriting agreement, subscription agreement, and the offering circular and (e)&nbsp;we and the underwriter shall individually or collectively keep the evidence of fulfillment of conditions (a)&nbsp;through (d)&nbsp;above after having
taken necessary actions therefor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Australia </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No prospectus or other disclosure document (as defined in the Corporations Act 2001 (Cth) of Australia (the &#147;Corporations Act&#148;)) in
relation to the shares has been, or will be, lodged with the Australian Securities and Investments Commission (&#147;ASIC&#148;), the Australian Securities Exchange operated by ASX Limited or any other regulatory body or agency in Australia. This
document has not been lodged with ASIC and is only directed to certain categories of exempt persons. Accordingly, if you receive this document in Australia: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">you confirm and warrant that you are either: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;sophisticated investor&#148; under section 708(8)(a) or (b)&nbsp;of the Corporations Act;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;sophisticated investor&#148; under section 708(8)(c) or (d)&nbsp;of the Corporations Act and that you
have provided an accountant&#146;s certificate to us which complies with the requirements of section 708(8)(c)(i) or (ii)&nbsp;of the Corporations Act and related regulations before the offer has been made; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a person associated with the Company under section 708(12) of the Corporations Act; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;professional investor&#148; within the meaning of section 708(11)(a) or (b)&nbsp;of the Corporations
Act, and to the extent that you are unable to confirm or warrant that you are an exempt sophisticated investor, associated person or professional investor under the Corporations Act any offer made to you under this document is void and incapable of
acceptance; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">you warrant and agree that you will not offer any of the shares for resale in Australia within 12 months of
those shares being issued unless any such resale offer is exempt from the requirement to issue a disclosure document under section 708 of the Corporations Act. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_12"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock being offered by this prospectus supplement and the accompanying prospectus and certain other legal
matters will be passed upon for us by Gibson, Dunn&nbsp;&amp; Crutcher LLP, Houston, Texas. Certain legal matters in connection with this offering will be passed upon for the selling stockholder by Covington&nbsp;&amp; Burling LLP and Potter
Anderson&nbsp;&amp; Corroon LLP. Certain legal matters will be passed upon for the underwriter by Cravath, Swaine&nbsp;&amp; Moore LLP, New York, New York. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom608413_13"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements as of December&nbsp;31, 2022 and 2021 and for each of the three years in the period ended
December&nbsp;31, 2022 and management&#146;s assessment of the effectiveness of internal control over financial reporting (which is included in Management&#146;s Assessment of Internal Control over Financial Reporting) as of December&nbsp;31, 2022
incorporated by reference in this prospectus supplement have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP (Canada), an independent registered public accounting firm, given on the authority of said firm as experts in
auditing and accounting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PricewaterhouseCoopers LLP (Canada) are the Company&#146;s auditors and have advised that they are independent
with respect to the Company within the meaning of the Rules of Professional Conduct of the Chartered Professional Accountants of Alberta and within the meaning of the Securities Act and the applicable rules and regulations thereunder adopted by the
SEC and the Public Company Accounting Oversight Board (United States). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain estimates of the Company&#146;s oil, NGLs and natural gas
reserves as of December&nbsp;31, 2022 incorporated by reference in this prospectus supplement were based upon evaluations prepared by the Company&#146;s internal qualified reserves evaluators and were audited by McDaniel&nbsp;&amp; Associates
Consultants Ltd. and Netherland, Sewell&nbsp;&amp; Associates, Inc. Such estimates have been so incorporated by the Company in reliance on the authority of such experts in such matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The combined financial statements of Black Swan Permian, LLC and Black Swan Operating, LLC as of and for the years ended December&nbsp;31,
2022 and 2021 and the statements of revenues and direct operating expenses of certain oil and gas properties of 1025 Investments, LLC for the years ended December&nbsp;31, 2022 and 2021 incorporated in this prospectus supplement by reference from
Exhibits 99.9 and 99.10, respectively, to the Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> of the Company dated May&nbsp;12, 2023, have been audited by Moss Adams LLP, independent auditors, as stated in their reports, which are
incorporated herein by reference. Such financial statements are incorporated by reference in reliance upon the reports of such firm given their authority as experts in accounting and auditing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain estimates of the oil, NGLs and natural gas reserves of Black Swan Permian, LLC, Black Swan Operating, LLC and certain interests in
1025 Investments, LLC as of December&nbsp;31, 2022 incorporated by reference in this prospectus supplement were based upon evaluations prepared by LaRoche Petroleum Consultants, Ltd. Such estimates have been so incorporated in reliance on the
authority of such experts in such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The audited historical financial statements of PetroLegacy Energy II, LLC and certain
interests of Peacemaker Royalties, LP included on page 13 of the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> dated May&nbsp;12, 2023 have been so incorporated in reliance on the report of PricewaterhouseCoopers
LLP, independent accountants, given on the authority of said firm as experts in auditing and accounting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The audited historical financial
statements of Pearlsnap Midstream, LLC included on page 41 of the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> dated May&nbsp;12, 2023 have been so incorporated in reliance on the report
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of PricewaterhouseCoopers LLP, independent accountants, given on the authority of said firm as experts in auditing and accounting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain estimates of the oil, NGLs and natural gas reserves of PetroLegacy Energy II, LLC and certain interests of Peacemaker Royalties, LP as
of December&nbsp;31, 2022 incorporated by reference in this prospectus supplement were based upon evaluations prepared by the internal qualified reserves evaluators of PetroLegacy Energy II, LLC and certain interests of Peacemaker Royalties, LP and
were audited by Cawley, Gillespie&nbsp;&amp; Associates, Inc. Such estimates have been so incorporated in reliance on the authority of such experts in such matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Piedra Energy III, LLC and subsidiary as of and for the year ended December&nbsp;31, 2022 and the
consolidated financial statements of Piedra Energy III, LLC and subsidiary as of and for the year ended December&nbsp;31, 2021 incorporated by reference in this prospectus supplement from Exhibits&nbsp;99.3 and 99.4, respectively, of our Current
Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> dated May&nbsp;12, 2023 have been so included in reliance on the reports of Weaver and Tidwell LLP, an independent registered public accounting firm, given on the authority of said firm as
experts in auditing and accounting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements of Piedra Energy IV, LLC as of and for the year ended December&nbsp;31, 2022
and the financial statements of Piedra Energy IV, LLC as of and for the year ended December&nbsp;31, 2021 incorporated by reference in this prospectus supplement from Exhibits 99.6 and 99.7, respectively, of our Current Report on <FONT
STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> dated May&nbsp;12, 2023 have been so included in reliance on the reports of Weaver and Tidwell LLP, an independent registered public accounting firm, given on the authority of said firm as experts in
auditing and accounting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain estimates of the oil, NGLs and natural gas reserves of Piedra Energy III, LLC and Piedra Energy IV, LLC
as of December&nbsp;31, 2022 incorporated by reference in this prospectus supplement were based upon evaluations prepared by Russell K. Hall and Associates, Inc. Such estimates have been so incorporated in reliance on the authority of such experts
in such matters. </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospectus </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g608413g00a12.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>31,777,596 Shares of Common Stock </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling stockholder named in this prospectus (the &#147;<B>selling stockholder</B>&#148;) may offer up to 31,777,596 shares of common stock (the
&#147;<B>Securities</B>&#148;), $0.01 par value per share (the &#147;<B>common stock</B>&#148;), of Ovintiv Inc. (the &#147;<B>Company</B>&#148;). Such Securities were issued by the Company to the selling stockholder in connection with an
acquisition by the Company (the &#147;<B>Permian Acquisition</B>&#148;) pursuant to a Securities Purchase Agreement, dated April&nbsp;3, 2023, by and among Black Swan Oil&nbsp;&amp; Gas, LLC, PetroLegacy II Holdings, LLC, Piedra Energy III Holdings,
LLC, and Piedra Energy IV Holdings, LLC, Black Swan Permian, LLC, Black Swan Operating, LLC, PetroLegacy Energy II, LLC, PearlSnap Midstream, LLC, Piedra Energy III, LLC, and Piedra Energy IV, LLC, and solely in its capacity as &#147;Sellers&#146;
Representative&#148; thereunder, NMB Seller Representative, LLC, and the Company (the &#147;<B>Purchase Agreement</B>&#148;). All of these shares of common stock are being sold by the selling stockholder named in this prospectus, or any of the
selling stockholder&#146;s permitted transferees. The selling stockholder will receive all proceeds from the sale of the shares of common stock being offered in this prospectus. We will not receive any proceeds from the sale of shares by the selling
stockholder. We are required to pay certain offering fees and expenses in connection with the registration of the selling stockholder&#146;s Securities and to indemnify the selling stockholder against certain liabilities. For more information
related to the selling stockholder, please read &#147;Selling Stockholder.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any prospectus supplement may also add, update, or change information
contained in this prospectus. You should read this prospectus and any prospectus supplement together with additional information described under the heading &#147;Where You Can Find More Information&#148; carefully before you invest in the
Securities. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Investment in the Securities involves certain risks. Please carefully review the information under the heading &#147;<A HREF="#tx608413_4">Risk
Factors</A>&#148; on page 5 of this prospectus, along with any risk factors described in the applicable prospectus supplement. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling
stockholder may sell the Securities to or through underwriters or dealers purchasing as principals and may also sell the Securities to one or more purchasers directly or through agents. See &#147;Plan of Distribution&#148; on page 13 of this
prospectus. The prospectus supplement relating to a particular offering of Securities will identify each underwriter, dealer or agent, as the case may be, engaged by us in connection with the offering and sale of Securities, and will set forth the
terms of the offering of such Securities, including the method of distribution of such Securities, the public offering price, any fees, discounts or other compensation payable to underwriters, dealers or agents, and any other material terms of the
plan of distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our shares of common stock are listed and posted for trading on the New York Stock Exchange (the &#147;<B>NYSE</B>&#148;) and on
the Toronto Stock Exchange (the &#147;<B>TSX</B>&#148;) under the symbol &#147;OVV&#148;. The last reported sale price of our common stock on July&nbsp;26, 2023, as reported by NYSE and TSX, was $43.10 per share and C$56.88 per share, respectively.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the United States Securities and Exchange Commission (the &#147;SEC&#148;) nor any state securities commission has approved or disapproved of
these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offence. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of
this prospectus is July&nbsp;27, 2023. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_3">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_5">OVINTIV INC.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_7">DESCRIPTION OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_8">SELLING STOCKHOLDER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_9">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_10">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx608413_11">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx608413_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement that we filed with the SEC utilizing a &#147;shelf&#148; registration statement process. Under this
process, the selling stockholder may offer and sell from time to time the Securities described in this prospectus in one or more offerings in amounts to be determined at the time of any offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus only provides you with a general description of the Securities that the selling stockholder may offer. Each time the selling stockholder
offers Securities, to the extent necessary and required by law, we will provide a supplement to this prospectus that contains specific information about the terms of that offering, including the specific amounts, prices and terms of the Securities
offered, the manner of distribution, the identity of any underwriters or other counterparties and other specific terms related to the offering. The prospectus supplement may also add, update or change information contained in this prospectus. To the
extent that any statement made in a prospectus supplement is inconsistent with statements made in this prospectus, the statements made in this prospectus will be deemed modified or superseded by those made in the prospectus supplement. You should
carefully read both this prospectus, any accompanying prospectus supplement and any free writing prospectus prepared by or on behalf of us, together with the additional information described under the heading &#147;Where You Can Find More
Information.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus does not contain all of the information set forth in the registration statement we have filed with the SEC (the
&#147;<B>Registration Statement</B>&#148;) of which this prospectus forms a part, certain parts of which are omitted in accordance with the rules and regulations of the SEC. You may refer to the Registration Statement of which this prospectus forms
a part and the exhibits to the Registration Statement for further information with respect to us and the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither we nor the selling
stockholder have authorized anyone to provide you with any information other than that contained in or incorporated by reference into this prospectus, any accompanying prospectus supplement and any free writing prospectus prepared by or on behalf of
us. Neither we nor the selling stockholder take any responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. Neither we nor the selling stockholder are making offers to sell the
Securities in any jurisdiction in which an offer or solicitation is not authorized or in which the person making such offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make an offer or solicitation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in this prospectus is accurate as of the date on the front cover. You should not assume that the information contained in this prospectus or
any prospectus supplement or in any document incorporate by referenced in this prospectus or any prospectus supplement is accurate as of any other date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless the context otherwise requires or otherwise expressly stated, all references in this prospectus and any prospectus supplement to &#147;Ovintiv&#148;,
the &#147;Company&#148;, &#147;we&#148;, &#147;us&#148; and &#147;our&#148; refer to Ovintiv Inc. and, where appropriate, its consolidated subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In this prospectus and in any prospectus supplement, unless otherwise specified or the context otherwise requires, all dollar amounts are expressed in United
States dollars, references to &#147;dollars&#148;, &#147;$&#148; or &#147;US$&#148; are to United States dollars and all references to &#147;C$&#148; are to Canadian dollars. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx608413_2"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC under the Securities Exchange Act of 1934, as amended (the
&#147;<B>Exchange Act</B>&#148;). The SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including Ovintiv, at www.sec.gov.
Ovintiv&#146;s SEC filings are also available on Ovintiv&#146;s website at www.ovintiv.com. Information on, or that is accessible from, our website, even if referred to in documents incorporated by reference in this prospectus, does not constitute
part of this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; information into this prospectus and any accompanying prospectus
supplement, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus and any accompanying
prospectus supplement, except for any information superseded by information contained directly in this prospectus, any accompanying prospectus supplement, any subsequently filed document deemed incorporated by reference or any free writing
prospectus prepared by or on behalf of us. This prospectus and any accompanying prospectus supplement incorporate by reference the documents set forth below that we have previously filed with the SEC (other than information deemed furnished and not
filed in accordance with SEC rules, including Items 2.02 and 7.01 of Form <FONT STYLE="white-space:nowrap">8-K).</FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1792580/000156459023002595/ovv-10k_20221231.htm">our
 Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2022, filed with the SEC on February&nbsp;27, 2023 (our &#147;<B>Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT></B>&#148;); </A> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the information specifically incorporated by reference into our <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1792580/000156459023002595/ovv-10k_20221231.htm">Annual
 Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT></A>&nbsp;from our&nbsp;
<A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1792580/000119312523077854/d386177ddef14a.htm">definitive proxy statement on Schedule 14A, filed on March&nbsp;23, 2023</A>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1792580/000095017023019797/ovv-20230331.htm">our
 Quarterly Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q&nbsp;for</FONT> the quarterly period ended March&nbsp;31, 2023, filed with the SEC on May&nbsp;9, 2023; </A> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1792580/000119312523089874/d444841d8k.htm">April&nbsp;4,
 2023</A>,&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000119312523120130/d304849d8k.htm">April&nbsp;27, 2023</A>,&nbsp;
<A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000095017023018829/ovv-20230503.htm">May&nbsp;
8, 2023</A>,<A HREF="http://www.sec.gov/Archives/edgar/data/1792580/000119312523143102/d280504d8k.htm"> May<U></U>&nbsp;12, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1792580/000119312523147571/d443234d8k.htm">May<U></U>&nbsp;18,
2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1792580/000119312523157968/d515741d8k.htm">May<U></U>&nbsp;31, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1792580/000119312523165428/d476002d8k.htm">June<U></U>&nbsp;12,
2023</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001792580/000119312523196183/d481107d8k.htm">July 27, 2023 (including Item 2.02)</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1792580/000119312520014164/d860981dex991.htm">the description of our
 capital stock contained in Exhibit 99.1 to our Form <FONT STYLE="white-space:nowrap">8-K12B,</FONT> filed with the SEC on January&nbsp;24, 2020, and any amendment or report filed for the purpose of updating such description. </A>
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All documents filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus and
before the termination of the offering also shall be deemed to be incorporated herein by reference. We are not, however, incorporating by reference any documents or portions thereof that are not deemed &#147;filed&#148; with the SEC, including any
information furnished pursuant to Items 2.02 or 7.01 of Form <FONT STYLE="white-space:nowrap">8-K.</FONT> Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document we previously
filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements. Any such statement so modified or superseded shall not be
deemed to constitute a part of this prospectus, except as so modified or superseded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If requested, we will provide to each person, including any
beneficial owner, to whom a prospectus is delivered, a copy of any or all of the information that has been incorporated by reference in the prospectus but not delivered with the prospectus. Exhibits to the filings will not be sent, however, unless
those exhibits have specifically been incorporated by reference into such documents. To obtain a copy of these filings at no cost, you may write or telephone us at the following address: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ovintiv Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">370 17th Street, Suite 1700 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Denver, CO 80202 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S.A. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(303) <FONT STYLE="white-space:nowrap">623-230</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention:
Corporate Secretary </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx608413_3"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus, any prospectus supplement and documents incorporated herein by reference contain certain forward-looking statements or information
(collectively, &#147;<B>forward-looking statements</B>&#148;) within the meaning of applicable securities legislation, including Section&nbsp;27A of the Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;), and Section&nbsp;21E
of the Exchange Act. All statements, except for statements of historical fact, that relate to the anticipated future activities, plans, strategies, objectives or expectations of the Company are forward-looking statements. When used in this
prospectus, any prospectus supplement and the documents incorporated herein by reference, the use of words and phrases including &#147;anticipates,&#148; &#147;believes,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimates,&#148;
&#147;expects,&#148; &#147;focused on,&#148; &#147;forecast,&#148; &#147;guidance,&#148; &#147;intends,&#148; &#147;maintain,&#148; &#147;may,&#148; &#147;opportunities,&#148; &#147;outlook,&#148; &#147;plans,&#148; &#147;potential,&#148;
&#147;strategy,&#148; &#147;targets,&#148; &#147;will,&#148; &#147;would&#148; and other similar terminology is intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words or phrases.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Without limiting the generality of the foregoing, forward-looking statements contained in this prospectus, any prospectus supplement and the documents
incorporated herein include statements regarding: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to consummate any pending acquisition and divestiture transactions;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to successfully integrate any acquired assets (including the Permian Acquisition) into
its business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">drilling plans and programs, including availability of capital to complete these plans and programs;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the composition of the Company&#146;s assets and the anticipated capital returns associated with its assets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated oil, natural gas liquids (&#147;NGLs&#148;) and natural gas prices; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the anticipated success of, and benefits from, technology and innovation, including the cube development model,
new or advanced drilling techniques or well completion designs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated drilling and completions activity, including the number of drilling rigs and frac crews utilized;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated proceeds and future benefits from various joint venture, partnership and other agreements;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated oil, NGLs and natural gas production and commodity mix; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s capital structure and ability to access credit facilities, credit markets and other sources of
liquidity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of the Company to timely achieve its stated environmental, social and governance goals, targets and
initiatives; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of changes in federal, state, provincial, local and tribal laws, rules and regulations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated compliance with current or proposed environmental legislation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to manage debt and financial ratios and comply with financial covenants;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the implementation and outcomes of risk management programs, including exposure to commodity prices, interest
rate and foreign exchange fluctuations and the volume of oil, NGLs and natural gas production hedged; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the declaration and payment of future dividends and the anticipated repurchase of the Company&#146;s outstanding
common shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to manage cost inflation and expected cost structures, including expected operating,
transportation, processing and labor expenses; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outlook of the oil and natural gas industry generally, including impacts from changes to the geopolitical
environment. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The forward-looking statements included in this prospectus, any prospectus supplement and the documents
incorporated herein involve risks and uncertainties that could cause actual results to differ materially from projected results. Accordingly, you should not place undue reliance on forward-looking statements as a prediction of actual results. We
have based these forward-looking statements on current expectations and assumptions about future events, taking into account all information currently known by us. While we consider these expectations and assumptions to be reasonable, they are
inherently subject to significant business, economic, competitive, regulatory and other risks and uncertainties, many of which are difficult to predict and beyond our control. The risks and uncertainties that may affect the operations, performance
and results of our business and forward-looking statements include, but are not limited to, the risk factors described in &#147;Risk Factors&#148; and those set forth in Item 1A. Risk Factors of the Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> and Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended March&nbsp;31, 2023; and other risks and uncertainties impacting our business as described from time to time in
our other periodic filings with the SEC or Canadian securities regulators. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we believe the expectations represented by the forward-looking
statements are reasonable based on the information available to us as of the date such statements are made, forward-looking statements are only predictions and statements of our current beliefs and there can be no assurance that such expectations
will prove to be correct. All forward-looking statements contained in this prospectus, any prospectus supplement and the documents incorporated herein are made as of the date of this prospectus or such prospectus supplement (or in the case of a
document incorporated herein by reference, the date of such document) and, except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements. The forward-looking statements contained or incorporated by
reference in this prospectus, any prospectus supplement and the documents incorporated herein are expressly qualified by these cautionary statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>You should read carefully the risk factors described herein and in the documents incorporated by reference in this prospectus for a description of certain
risks that could, among other things, cause actual results to differ from these forward-looking statements. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx608413_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investing in our Securities involves risk. Before you decide whether to purchase any of our Securities, in addition to the other information, documents, or
reports included in or incorporated by reference into this prospectus and any accompanying prospectus supplement or other offering materials, you should carefully consider the risk factors in the section entitled &#147;Risk Factors&#148; in any
prospectus supplement as well as our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> our Quarterly Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q&nbsp;for</FONT> the quarter ended March&nbsp;31, 2023<I>
</I>and our other filings with the SEC, which are incorporated by reference into this prospectus and any prospectus supplement in their entirety. For more information, see &#147;Where You Can Find More Information.&#148; These risks could materially
and adversely affect our business, results of operations and financial condition and could result in a partial or complete loss of your investment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx608413_5"></A>OVINTIV INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ovintiv is a leading North American oil and natural gas exploration and production company focused on developing its multi-basin portfolio of <FONT
STYLE="white-space:nowrap">top-tier</FONT> oil and natural gas assets located in the United States and Canada. Ovintiv&#146;s operations also include the marketing of oil, NGLs and natural gas. As of December&nbsp;31, 2022, all of Ovintiv&#146;s
reserves and production are located in North America. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a Delaware corporation, and our principal office is located at 370 17th Street, Suite 1700,
Denver, Colorado 80202, U.S.A. Our shares of common stock are listed and posted for trading on the NYSE and the TSX under the symbol &#147;OVV&#148;. We maintain a website at www.ovintiv.com. Information on, or that is accessible from, our website,
even if referred to in documents incorporated by reference in this prospectus, does not constitute part of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx608413_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are registering the resale of the 31,777,596 shares of common stock offered by the selling stockholder. All of the shares of common stock offered by the
selling stockholder pursuant to this prospectus will be sold by them. We are not selling any securities under this prospectus and will&nbsp;not&nbsp;receive&nbsp;any proceeds from the sales covered hereby. The net proceeds from the sale of the
common stock will be received by the selling stockholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx608413_7"></A>DESCRIPTION OF COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of the material terms of the capital stock of Ovintiv. The summary in this prospectus is not complete. You should read the complete
text of Ovintiv&#146;s certificate of incorporation (the Certificate of Incorporation) and amended and restated bylaws (the &#147;<B>Bylaws</B>&#148;) as currently in effect for more details regarding the provisions described below and for other
provisions that may be important to you. We have filed copies of those documents with the SEC, and they are incorporated by reference as exhibits to the registration statement of which this prospectus is a part. See &#147;Where You Can Find More
Information.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Certificate of Incorporation authorizes 750,000,000 shares of common stock, par value $0.01 per share. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Exchange Listings </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares of common stock of Ovintiv are listed on the NYSE and the TSX under the symbol &#147;OVV&#148;. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Voting Rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each holder of shares of common
stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors. Accordingly, holders of a majority of the voting shares are able to elect all of the directors of Ovintiv,
subject to the rights, if any, of holders any series of preferred stock to elect additional directors under specific circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dividends
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to preferences that may be applicable to any then outstanding shares of any series of preferred stock, holders of shares of common stock
are entitled to receive dividends, if any, as may be declared from time to time by the Board of Directors out of legally available funds. Declaration and payment of any dividend will be subject to the discretion of the Board of Directors and may be
paid in cash, in property or in shares of common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of Ovintiv&#146;s liquidation, dissolution or winding up, holders of shares of common stock are entitled to share ratably in the net assets
legally available for distribution to stockholders after the payment of all of Ovintiv&#146;s debts and other liabilities and the satisfaction of any liquidation preference or other similar rights granted to the holders of any then outstanding
shares of any series of preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Rights and Preferences </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of shares of common stock have no <FONT STYLE="white-space:nowrap">pre-emptive,</FONT> conversion, subscription or other rights, and there are no
redemption or sinking fund provisions applicable to shares of common stock. The rights, preferences and privileges of the holders of shares of common stock are subject to and may be adversely affected by the rights of the holders of shares of any
series of preferred stock that Ovintiv may designate in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fully Paid and
<FONT STYLE="white-space:nowrap">Non-Assessable</FONT></I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All outstanding shares of common stock are fully paid and
<FONT STYLE="white-space:nowrap">non-assessable</FONT> and any additional common stock that Ovintiv may issue will, when issued, be fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Uncertificated Shares </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of shares of common
stock of Ovintiv do not have the right to require Ovintiv to issue certificates for their shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Transfer Agent and Registrar </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for the shares of common stock is American Stock Transfer&nbsp;&amp; Trust Company, LLC (&#147;<B>AST</B>&#148;). AST&#146;s
address is 6201 15th Avenue, Brooklyn, New York, 11219. AST, at its Canadian office, at AST Trust Company (Canada), P.O. Box 700, Station B, Montreal, QC H3B 3K3, acts as <FONT STYLE="white-space:nowrap">co-transfer</FONT> agent. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Annual Stockholder Meetings </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Bylaws provide that
annual stockholder meetings will be held at a date, place (if any) and time, as exclusively selected by the Board of Directors. To the extent permitted under applicable law, Ovintiv may, but is not obligated to, conduct annual stockholder meetings
by remote communications, including by webcast. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of Provisions of the Certificate of Incorporation and Bylaws and Delaware Law
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some provisions of Delaware law and the Certificate of Incorporation and Bylaws could make the following transactions difficult: acquisition of
Ovintiv by means of a tender offer, merger or otherwise, or removal of incumbent officers and directors of Ovintiv by means of a proxy contest or otherwise. It is possible that these provisions could make it more difficult to accomplish or could
deter transactions that stockholders may otherwise consider to be in their best interest or in the best interests of Ovintiv, including transactions that might result in a premium over the market price for shares of common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover proposals. These provisions are also
designed to encourage persons seeking to acquire control of Ovintiv to first negotiate with the Board of Directors. Ovintiv believes that the benefits of Ovintiv&#146;s potential ability to negotiate with the proponent of an unfriendly or
unsolicited proposal to acquire or restructure Ovintiv outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Special Stockholder Meetings </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Bylaws provide
that a special meeting of stockholders may be called only by the Board of Directors or by one or more stockholders of record holding at least 20% of the voting power of all outstanding shares of common stock. This may limit the ability of Ovintiv
stockholders to take action between annual meetings without the prior approval of the Board of Directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restriction on Stockholder Action by
Written Consent </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Certificate of Incorporation does not permit stockholders to take action by written consent. This restriction forces
stockholder action to be taken at annual and special meetings of Ovintiv stockholders and could delay the ability of stockholders to force consideration of a stockholder proposal or take action, including the removal of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Requirements for Advance Notification of Stockholder Nominations and Proposals and Proxy Access </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Bylaws establish advance notice procedures with respect to stockholder proposals, the nomination of candidates for election as directors, other than
nominations made by or at the direction of the Board of Directors or a committee of the Board of Directors and the inclusion of any such nominees in the proxy materials of Ovintiv. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Composition of the Board of Directors; Election and Removal of Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors consists of one or more members, the number thereof to be determined from time to time by the Board of Directors. The directors of
Ovintiv are elected until the expiration of the term for which they are elected and until their respective successors are duly elected and qualified. At each annual meeting of Ovintiv, directors will be elected to
<FONT STYLE="white-space:nowrap">one-year</FONT> terms that expire at the next annual meeting of stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the rights, if any, of holders of any series of preferred stock with respect to removal without
cause of directors elected by such holders, the directors of Ovintiv may be removed with or without cause at any time by the holders of a majority of the voting power of Ovintiv&#146;s then-outstanding common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors on the Board of Directors will be elected by the vote of the majority of the votes cast with respect to the director at any meeting for the election
of directors at which a quorum is present, except if, as of the date that is 14 days before Ovintiv files its definitive proxy statement (regardless of whether or not thereafter revised or supplemented) with the SEC, the number of director nominees
exceeds the number of directors to be elected, in which case directors on the Board of Directors will be elected by the vote of a plurality of the shares represented in person or by proxy at the meeting and entitled to vote on the election of
directors. Unless plurality voting shall have applied to the election, any director who receives a greater number of &#147;against&#148; votes than votes &#147;for&#148; election shall offer to tender his or her resignation to the Board of
Directors. In that event, the Nominating and Corporate Governance Committee of the Board of Directors will make a recommendation to the Board of Directors on whether to accept or reject the resignation, or whether other action should be taken. The
Board of Directors will act on such recommendation within 90 days following certification of the election results. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Exclusive Forum </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Certificate of Incorporation provides that, unless Ovintiv consents in writing to the selection of an alternative forum, and subject to applicable
jurisdictional requirements, the Court of Chancery of the State of Delaware will be the exclusive forum (or if the Court of Chancery of the State of Delaware lacks jurisdiction, then another court of the State of Delaware or, if no court of the
State of Delaware has jurisdiction, then the United States District Court for the District of Delaware) for: (a)&nbsp;any derivative action or proceeding brought on behalf of Ovintiv; (b)&nbsp;any action asserting a breach of fiduciary duty owed by
any current or former director, officer or stockholder of Ovintiv to Ovintiv or Ovintiv&#146;s stockholders; (c)&nbsp;any action asserting a claim arising pursuant to any provision of the General Corporation Law of the State of Delaware (the
&#147;<B>DGCL</B>&#148;); or (d)&nbsp;any action asserting a claim governed by the internal affairs doctrine. The exclusive forum provision does not purport to apply to suits brought to enforce a duty or liability created by the Securities Act or
the Exchange Act, or any rules or regulations promulgated thereunder, or any other claim for which the United States federal courts have exclusive jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Such provision may limit the ability of an Ovintiv stockholder to bring a claim in a judicial forum that it finds favorable for disputes with directors,
officers or other matters pertaining to Ovintiv&#146;s internal affairs, and may discourage lawsuits with respect to such claims. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Business
Combinations Involving Interested Stockholders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In general, Section&nbsp;203 of the DGCL (&#147;<B>Section</B><B></B><B>&nbsp;203</B>&#148;) prohibits
a publicly held Delaware corporation from engaging in a business combination with an interested stockholder for a period of three years following the date that such person became an interested stockholder, unless the business combination or the
transaction in which such person became an interested stockholder is approved in a prescribed manner. Generally, a &#147;business combination&#148; is defined to include a merger, consolidation, a sale of assets and other transactions resulting in a
financial benefit to the interested stockholder. Generally, an &#147;interested stockholder&#148; is a person that owns (or is an affiliate or associate of the corporation and within the prior three years did own) 15% or more of a corporation&#146;s
voting stock, and the affiliates and associates of any such person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These restrictions do not apply if, among other things, the corporation&#146;s
certificate of incorporation contains a provision expressly electing not to be governed by Section&nbsp;203. The Certificate of Incorporation opts out of Section&nbsp;203. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations of Liability and Indemnification Matters </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Certificate of Incorporation contains provisions that limit the liability of the directors of Ovintiv for monetary damages to the fullest extent permitted by Delaware law. Consequently, Ovintiv directors will not be
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
personally liable to Ovintiv or its stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any breach of the director&#146;s duty of loyalty to Ovintiv or its stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">willful or negligent declaration and payment of unlawful dividends, or unlawful share purchases or redemptions;
or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any transaction from which the director derived an improper personal benefit. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Certificate of Incorporation provides that Ovintiv is required to indemnify its directors and officers, in each case to the fullest extent permitted by
Delaware law. The Certificate of Incorporation also obligates Ovintiv to advance expenses incurred by a director or officer in advance of the final disposition of any action or proceeding. In addition, Ovintiv has entered into agreements with
Ovintiv directors and officers to indemnify such directors and officers. With specified exceptions, these agreements provide for indemnification against all liability and loss suffered and expenses (including attorneys&#146; fees), judgments, fines
and amounts paid in settlement by any of these individuals in any action, suit or proceeding, to the fullest extent permitted by applicable law. In addition, Ovintiv maintains directors&#146; and officers&#146; liability insurance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The limitation of liability and indemnification provisions in the Certificate of Incorporation may discourage stockholders from bringing a lawsuit against
Ovintiv directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against Ovintiv directors and officers, even though an action, if successful, might benefit Ovintiv and its stockholders.
Furthermore, a stockholder&#146;s investment may be adversely affected to the extent that Ovintiv pays the costs of settlement or damages. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx608413_8"></A>SELLING STOCKHOLDER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus relates to 31,777,596 shares of our common stock, which were issued by the Company to the selling stockholder pursuant to the
Purchase Agreement. The filing of the registration statement of which this prospectus forms a part is pursuant to our obligations under the registration rights agreement, dated June&nbsp;12, 2023, between the Company and the selling stockholder,
which was executed in connection with the closing of the transactions contemplated by the Purchase Agreement. We agreed to pay certain offering fees and expenses in connection with the registration of the selling stockholder&#146;s Securities and to
indemnify the selling stockholder against certain liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information contained in the table below in respect of the selling
stockholder (including the number of shares of common stock beneficially owned and the number of shares of common stock offered) has been obtained from the selling stockholder and has not been independently verified by us. We may supplement this
prospectus from time to time in the future to update or change this list of selling stockholder(s) and the number of shares of common stock that may be offered and sold by any selling stockholder. The registration for resale of the shares of common
stock does not necessarily mean that the selling stockholder will sell all or any of these shares. In addition, the selling stockholder may have sold, transferred or otherwise disposed of, or may sell, transfer or otherwise dispose of, at any time
and from time to time, shares of common stock in transactions exempt from the registration requirements of the Securities Act, after the date on which it provided the information set forth in the table below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information set forth in the following table regarding the beneficial ownership after resale of the shares of common stock is based upon
the assumption that the selling stockholder will sell all of the shares of common stock beneficially owned by it that are covered by this prospectus. Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or
investment power with respect to shares of common stock and the right to acquire such voting or investment power within 60 days through the exercise of any option, warrant or other right. To our knowledge and subject to applicable community property
rules, the selling stockholder named in the table has sole voting and sole investment power with respect to all equity interests beneficially owned. Except as described in the footnotes to the following table, the selling stockholder named in the
table have not held any position or office or had any other material relationship with us or our affiliates during the three years prior to the date of this prospectus. The inclusion of any shares of common stock in the footnotes of this table does
not constitute an admission of beneficial ownership for the selling stockholder named below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of July&nbsp;17, 2023, there were
273,858,158&nbsp;shares of our common stock issued and outstanding. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Name of selling</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of Common<BR>Stock<BR>beneficially owned<BR>prior to the<BR>offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Common<BR>Stock to be<BR>offered</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of Common<BR>Stock<BR>beneficially owned<BR>after the<BR>offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NMB Stock Trust (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,777,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,777,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Less than 1%. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares of common stock held by the selling stockholder are beneficially owned by Wilmington Trust, National
Association, in its capacity as Administrative Trustee of the selling stockholder (&#147;Wilmington&#148;). Wilmington, in its fiduciary capacity as administrative trustee of the selling stockholder, is deemed to have sole voting and investment
power over such shares. The various beneficiaries of the selling stockholder have the right to receive any dividends paid with respect to the shares reported herein and to receive the proceeds from the sale of the shares reported herein.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx608413_9"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this prospectus, we have not been advised by the selling stockholder as to any plan of distribution. Distributions of the
shares of common stock by the selling stockholder, or by the selling stockholder&#146;s permitted transferees, may from time to time be offered for sale either directly by such individual, or through underwriters, dealers or agents or on any
exchange on which the shares of common stock may from time to time be traded, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, or in independently negotiated transactions or otherwise.
The methods by which the shares of common stock may be sold include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">underwritten transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exchange distributions and/or secondary distributions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales on the NYSE or any other U.S. securities exchange, or the TSX, on which the common stock may be listed or
quoted at the time of sale; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions and transactions in which the broker solicits purchasers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">broker-dealers may agree with the selling stockholder to sell a specified number of such shares at a stipulated
price per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a block trade (which may involve a cross trade) in which the broker or dealer so engaged will attempt to sell the
Securities as agent but may position and resell a portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases by a broker or dealer as principal and resale by such broker or dealer for its own account pursuant to
this prospectus; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">short sales; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through the writing of options on the shares, whether or not the options are listed on an options exchange;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a combination of any such methods; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other method permitted pursuant to applicable law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder may also sell shares of common stock pursuant to an exemption from regulation pursuant to Rule 144 under the
Securities Act, if available, rather than under this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transactions may be effected by the selling stockholder at market prices
prevailing at the time of sale or at negotiated prices. The selling stockholder may effect such transactions by selling the Securities to underwriters or through broker-dealers, and such underwriters or broker-dealers may receive compensation in the
form of discounts or commissions from the selling stockholder and may receive commissions from the purchasers of the Securities for whom they may act as agent. The selling stockholder may agree to indemnify any underwriter, broker-dealer or agent
that participates in transactions involving sales of the shares of common stock against certain liabilities, including liabilities arising under the Securities Act. We have agreed to register the shares of common stock for sale under the Securities
Act and to indemnify the selling stockholder and each person who participates as an underwriter in the offering of the shares of common stock against certain civil liabilities, including certain liabilities under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with sales of the Securities under this prospectus, the selling stockholder may enter into hedging transactions with
broker-dealers, who may in turn engage in short sales of the Securities in the course of hedging the positions they assume. The selling stockholder also may sell the Securities short and deliver them to close its short positions, or loan or pledge
the Securities to broker-dealers that in turn may sell them. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder may from time to time pledge or grant a security interest in some or
all of the shares of common stock owned by such selling stockholder and, if such selling stockholder defaults in the performance of its secured obligations, the pledgees or secured parties may offer and sell shares of common stock from time to time
under this prospectus, or under an amendment to this prospectus under Rule 424 or other applicable provision of the Securities Act amending the list of selling stockholder to include the pledgee, transferee or other successors in interest as a
selling stockholder under this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder and any underwriters, dealers or agents that participate in
distribution of the Securities may be deemed to be underwriters, and any profit on sale of the Securities by them and any discounts, commissions or concessions received by any underwriter, dealer or agent may be deemed to be underwriting discounts
and commissions under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurances that the selling stockholder will sell any or all of the Securities
offered under this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx608413_10"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gibson, Dunn&nbsp;&amp; Crutcher LLP will pass upon the validity of any Securities issued under this prospectus. Any underwriters will be represented by their
own legal counsel. If any legal matters relating to the offerings made in connection with this prospectus are passed upon by agents, dealers or underwriters, such counsel will be named in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx608413_11"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements as of December&nbsp;31, 2022 and 2021 and for each of the three years in the period ended December&nbsp;31, 2022 and
management&#146;s assessment of the effectiveness of internal control over financial reporting (which is included in Management&#146;s Assessment of Internal Control over Financial Reporting) as of December&nbsp;31, 2022 incorporated by reference in
this prospectus have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PricewaterhouseCoopers LLP (Canada) are the Company&#146;s auditors and have advised that they are independent with respect to the Company within the meaning
of the Rules of Professional Conduct of the Chartered Professional Accountants of Alberta and within the meaning of the Securities Act and the applicable rules and regulations thereunder adopted by the SEC and the Public Company Accounting Oversight
Board (United States). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain estimates of the Company&#146;s oil, NGLs and natural gas reserves as of December&nbsp;31, 2022 incorporated by reference
in this prospectus were based upon evaluations prepared by the Company&#146;s internal qualified reserves evaluators and were audited by McDaniel&nbsp;&amp; Associates Consultants Ltd. and Netherland, Sewell&nbsp;&amp; Associates, Inc. Such
estimates have been so incorporated by the Company in reliance on the authority of such experts in such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The combined financial statements of
Black Swan Permian, LLC and Black Swan Operating, LLC as of and for the years ended December&nbsp;31, 2022 and 2021 and the statements of revenues and direct operating expenses of certain oil and gas properties of 1025 Investments, LLC for the years
ended December&nbsp;31, 2022 and 2021 incorporated in this prospectus by reference from Exhibits 99.9 and 99.10, respectively, to the Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;of</FONT> Ovintiv Inc. dated May&nbsp;12,
2023, have been audited by Moss Adams LLP, independent auditors, as stated in their reports, which are incorporated herein by reference. Such financial statements are incorporated by reference in reliance upon the reports of such firm given their
authority as experts in accounting and auditing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain estimates of the oil, NGLs and natural gas reserves of Black Swan Permian, LLC, Black Swan
Operating, LLC and certain interests in 1025 Investments, LLC (the &#147;Black Swan Subject Companies&#148;) as of December&nbsp;31, 2022 incorporated by reference in this prospectus were based upon evaluations prepared by LaRoche Petroleum
Consultants, Ltd. Such estimates have been so incorporated in reliance on the authority of such experts in such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audited historical financial
statements of PetroLegacy Energy II, LLC and certain interests of Peacemaker Royalties, LP included on page 13 of the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> dated May&nbsp;12, 2023 have been so incorporated
in reliance on the report of PricewaterhouseCoopers LLP, independent accountants, given on the authority of said firm as experts in auditing and accounting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audited historical financial statements of Pearlsnap Midstream, LLC included on page 41 of the Company&#146;s Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> dated May&nbsp;12, 2023 have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, independent accountants, given on the authority of said firm as experts in auditing and accounting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain estimates of the oil, NGLs and natural gas reserves of PetroLegacy Energy II, LLC and certain interests of Peacemaker Royalties, LP as of
December&nbsp;31, 2022 incorporated by reference in this prospectus were based upon evaluations prepared by the internal qualified reserves evaluators of PetroLegacy Energy II, LLC and certain interests of Peacemaker Royalties, LP and were audited
by Cawley, Gillespie&nbsp;&amp; Associates, Inc. Such estimates have been so incorporated in reliance on the authority of such experts in such matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Piedra Energy III, LLC and subsidiary as of and for the year ended December&nbsp;31, 2022 and the consolidated
financial statements of Piedra Energy III, LLC and subsidiary as of and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for the year ended December&nbsp;31, 2021 incorporated by reference in this prospectus from Exhibits 99.3 and 99.4, respectively, of our Current Report on
<FONT STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;dated</FONT> May&nbsp;12, 2023 have been so included in reliance on the reports of Weaver and Tidwell LLP, an independent registered public accounting firm, given on the authority of said firm as
experts in auditing and accounting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Piedra Energy IV, LLC as of and for the year ended December&nbsp;31, 2022
and the consolidated financial statements of Piedra Energy IV, LLC as of and for the year ended December&nbsp;31, 2021 incorporated by reference in this prospectus from Exhibits 99.6 and 99.7, respectively, of our Current Report on <FONT
STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;dated</FONT> May&nbsp;12, 2023 have been so included in reliance on the reports of Weaver and Tidwell LLP, an independent registered public accounting firm, given on the authority of said firm as experts
in auditing and accounting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain estimates of the oil, NGLs and natural gas reserves of Piedra Energy III, LLC and Piedra Energy IV, LLC as of
December&nbsp;31, 2022 incorporated by reference in this prospectus were based upon evaluations prepared by Russell K. Hall and Associates, Inc. Such estimates have been so incorporated in reliance on the authority of such experts in such matters.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:80pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>8,400,000 shares </B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g608413g86o24.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Ovintiv Inc. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:68pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS
SUPPLEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:68pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Goldman Sachs&nbsp;&amp; Co. LLC </B></P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023 </I></B></P>
<P STYLE="font-size:80pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g608413g00a12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g608413g00a12.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ .0"= P$1  (1 0,1 ?_$ !P
M 0 " P$! 0             ("08'"@0#!?_$ "\0  (" @(" 00" 0(' 0
M  0% P8"!P$(  D3"A(4%1$6%QDC&"$Y.G9WM+C_Q  ; 0$  @(#
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MX<8\JQ"QPPSP 2.W>KV&WJRZH^M'U\>T;_AB77Q?_FKIMN+^[_W:YSV[YO\
M'&DMU_UK]9\P(?Z_X_[X_P#S?M^3\O[Q/N^S\;C[U1[V8KN.<'C@#N1[@/=5
M/OJ4Z>"]Z_IRNS77>$* JY/=X;AM&J9YN(\,PMLT:MZQM-"XB*D_C\&%RZ6Q
M5=N7A_.6-??MX><9,)LX\U22-ME!]P&?B/6I9^D+V9)*3Z5MSV;;1?,EO];*
MB_55VA<32"N6]8A .M&D49$4O,<@,KEJ:3II ++B/)@34(H9>,,N.9LE:R(=
M_'9SD?$GO]3\JPGZ<3H35MQ=;=X]X^VU$1[3O?<C=;RUH";NJC8\R5ZG.K5
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M,9'BI$==H9CYDS@9Y.1]>./OKO>T-IJF]=M*:IT/KT3\.DZ@U_5->5J++"/
MB975$PBB$\[*/CCB=HSY%R9-2\ONE-9%E%S9R33R9Y*@))))Y)Y-;9\5BGBE
M5,^SF^]J#AJ+UTZTT*WL/\Q"EC7*_5E8UE_6KICHU4=6GL<(V">GA,XY)R[
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,4IXI3Q2GBE/%*__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g608413g86o24.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g608413g86o24.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( #L H0,!$0 "$0$#$0'_Q  >  $
M @,  P$!            " D&!PH"! 4! __$ "X0  $$ @(" 0,"!@,!
M  0" P4& 0< " D1$A,4(146"B(C,4%1%QAA,O_$ !P! 0 !!0$!
M       ! @4&!P@#!/_$ #01  (" @(! @0$! 8# 0    (# 00 !081!Q(A
M$Q0Q\!5!47$B8:'!"#*!D;'1%A?A\?_:  P# 0 "$0,1 #\ [^.,8XQCC&.,
M9ZIIHD:$7(GD-" @"D&FEOKPVP*(*TM\DAYQ7X0TRRVMQQ>?PE"<JS^,<\+-
ME%.M8MVG+KU:J&V;+VE *2A"R:YS"GV%:UB1F4^PB,S/TSU0AUEZ:U=9N?8:
MM"$K&28US3A:U@,>Y&9D(B,>\E,1&5H5KM%N#L)V*@ZUH=O,5IBHS,<1>IL^
M'C756&MLR32Y4HXR5CC2(3,R*,5'56+BU!33_P!5R0->'PV1B$XTTWF[R!Y9
M\N:S3>+@FCXZT.PIMY-L;>OJ&6VTR[BRO/LV+U.P[63L4)?4T=&G-;8M^(=J
MRQ7I;&MZ?V?BKAOCKQO?VG/RBWS7<4K*M#1KW;(1KMF=8XJ*0FI90N]%)S56
M=M;M0^BN "N@#DES>LYYVEG+>.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8
MXQFIYK9G[;NBJ_.1OVD(\V,H.:QEW.59?894I]QO*<H<%9*4^,\IG/U&OI_4
MRE7Q4G-4#W'<3W/YQE,EU/4Q[3])^_YYM5MQ#J$.M+0XTXA+C;C:L+0XA>,*
M0M"TYRE2%)SA25)SG"L9QG&<XSRG*L@1Y#NV>R>FNH:]MNA:J%VC%_O4""O2
M#294,.KU\\(U8TR2=%,%*CT%R[(4*R<<.X T;(B,N8402,P]B',^17N,ZU.Q
MJ:X=@'S0JM01, :Z3 Y%I$L2D()D"J"*/1!&,3[D,3N/PIXXT7E#DUWC6XY$
MSC]B=4ZWJ)4NNUFPNI:J&5058-<.E=8FVB4DQ<2D-(>@ S#;?7SM[I'L;HY.
M^J?;(V*J,9&DEWQBQ'A1INM3XL'[Z=B[GEUY(\8J*'PLK$BMS$;(1GT98 E\
M$AMW-PTW)-5N]5^+UK +K+ BN"\P Z)K'UM7:[GTK^&/\4',^@U], I HG,;
MYIXTY9P?EL\.VFM?8V;WK7J"I):]6]38;\&I8U?I"3L18.87\&!^.FQZJS@!
MP$.0BZY>29WNCVJNVB=7ZA<FNMT+6+"BP;<D53+!QK& B  R28_#(P4'%6^2
M4Z!7XX]_]PEQK+\FZP$^@X"*Q#6\P3S+<;'CR-5\UQUE&W7NW6RX9?7<DT&)
M@,!"57/6:E#)P\EP3.@*#%6V>;>#/_5/C[3\RWW)AI\[L;&B='C:(JFI#(<#
MS%;I(VV[.L2(.NN4$TE/(*XFT)4ZS:'0-:435D*Y7M?5B-J\0\6Z>^+'H=RH
MHUY*$+)+*)=?,+>^FVVRVLDAW+3#;;#7P9;0A.4<5X;Q?A&N+4\4TM/2:]CS
MM-14$YEUAD").>YQML/9Z!%8DYIRM8 H/2L!&-"<AY/O^5WAV/(MI:VMP$A7
M6ZR0]*0$S(J2I0K2D/41&0J6$&PC8?J,B*<YYDV6+'&,<8QQC'&,<8QQC'&,
M<8QQC'&,<8QQC'&,<8S&K34XBWQWZ?*M+_D7]08MC*$%AN_C"ECN+0XG&%IQ
M\'6UH6TXGU\D?)#:D3$S$]QD3$3]?_N5]=EO)+UGZ';9TIUYW8G845_R?!LR
M45LD:'@I"@52+7/&P."[O(9L %@!8&.'PLQ^&JTRP#'OLF$J;901EF>I+N?]
M?]_TQ$=1U^F3SMLCKJ3UU89>['U _5,A4)&3L\K82XDFBF44J)=+DY&6/-<7
M"/UDB$6Z2480ZJ.<C5J?6YD=7SSXN2JPIB'K!R7 2VJ8,&MBSB1(# HF"$HF
M8D9B8F)ZSZJ=RUK[=:]1LOIW:;U6:EJLTTV*UA!PQ+TM7(FMJF")@8%!"41,
M3$QG*_J.W^,&QZ0\EP6E2>X2M,QKFD<;(* "UIAIV"=WBMJB+T=FPR*9DJ&<
MFFUID<[49!F\4I6592Y-9(3S5NXX;QSB_'N2V#;N(UVR_#_FJ]1E5CZX)V:B
M0%/XZP&0%KA%DV6M+Y>#Z*6>Y=6\1\R^2O*7D/QAKU5>&ER7C<\B_"=AMT;6
MK1V+[?&;:KS]U^'OL,%A5:;&UXUM6LO\0)<DL43Z0O2\9['4UGJ_6%=15$.4
MYU]:K@[9,1^-FKO6&&<2J=HI SEINT-M9'PRT'G,"F(R JKY7 +!<7DG!8X[
M&@K_ /CDE-:9GYJ7P$7YM]1\2-A >T6(CKTP,RGX7H^7F42$SK#SP?D<O(&P
MCR5 #M!"(U@T?C3H(U'K+Y:>/2[HBU\EZY(F1%R;/QHV$#=APCO&[]J]6TC;
M-2TP^Y,SUUM4S#0;C-=&CC0*R;/GB 1J+*45* K$6Y]VDQX8%B1.& 3]P0*W
M@@-).'<E\Y<(XSSO0>.FEL=IR3>['7:PUZA-2Q5TMC:VD5:<;E[[M8D$?QQL
M,357;LIJC\9J AM<76;1^)>5[WB.WYLL:6OT>II7;XGLFV46-HC7UW6+1:M2
MJCX= _!E -L,K(;8GX2VE\-TJDIS<>:QRFGR$^877W3J^1O7S5.N9KLAVBF\
M1J$:UJY)34=5GYUIIV!"L943&SDU)6>88(&D(JD5^(?E#(UY@J0D()J0B')&
MJ![]^^H_6<9 Z<\Q'E(T*$-LKM'XU<P>E,OCKE9B B-CU"0@ "W4--N35AES
M[W$PI>,NH0PQ9(& 0:7E .'1'7L*;GTQ,]>K^G_W&7T]1>W6F>Z^FX?=>DYH
M@Z -)>B9V"EV60K32;0&R._(U6U1K)!;0<J&T4*2VX,47'24>6')Q9I@!;#Z
MZ9B8GJ<9)[D8SYTP\>/$2A$4P@J48CCGHT9W&<MDGM#.K#8<QAUG.4/$);;7
MC#S6<I5G&'6__K#&0%\>VV>^&V:=L.0[WZ,I>C;9$66*"H452Q"1!IVNOQ:W
MY.0-23L;8V5OC26$#-Y2;&XPWG.,BO9_JXF>N_:>X^_Y1C+"^1C'&,KFZU^1
M6I=DNW/9GJ3#ZVL=8GNM!EC$F;A)3<8=$6A5=NC-,>7&1HHS1@*22'L&MX*>
M=RAE.6E>UY^7)F.HB?U[_IC/SMUM_O\ 4#?/7>K=5]#4C:&DK=+1+&^[I9!"
MGYBB1;]RB8Z4*A'6=E4YMIP6I/R<LWEROV3&"AFU99>3C(3R.NI[GW_+[ZQE
MC7(QCC&.,8XQCC&0?[]=(]']Y-&3.O\ <.!:Z=7A9*?H>UVFA436K9UL3*G9
MQ@HET9HFND-#M-VROFECQLW&,)4M\"4 B)F+\;%JO1KON6[":M2JEMBS9L-!
M->O72$L<Y[F$*U)4L2-C#(0 !DBF(B9SU0A]IZ:U9+;%BPU:4(2LFN<YI0"U
M*6$$;&,,A   9(BF!&)F8C*!-F=7YVH>,#775O9WDMU+5:"]VCD8UF_R[NP\
MTF3H#-*BI6'THA"H=B2>9K=GS(W]F)ER1*H.AZ/Q@]A,8&@"R<6YAQKFM!NV
MXIMJF[UR+;:#;5.62H+B5(>U$_%6LO6"K*#GH9'TM'J9]XB[[_C>]XM=7KN0
M:VQJKK:P7%UK,!#"K,8U2W1 &<>DF(<$=S$]K+N.NN^@OJ7TAZX]7>MX>@];
M5J%M5%M,)EV_6&<%C)HK<A<Y&)'D[%:R$(>!E@Y<%WZ,;',Y<AXN%4/'Q;:1
M4?4=OKU*M*:BPL')<!*:EHP:V+.)$P,"B1(2&9B8F)B8GWRVTKMS6W*VPU]E
M]*]2>JS4MUFFFQ6L).&*<EJY$UL68P0D,Q,3'<95WH'KIJ+J%Y MKT/1G<>F
MPHU@U?=9.6ZV%2$[*7>JHS5#K%"DSS@H<C FAZ_=6BRPI4P2-<1JT5]J^P;B
M0(.G=3?^#V^*MY'MM/OPU6J;H]M(S8AI?ASHI/.O;=, T7(U;X^96V0)\*$E
M2+"(R;TYRKSO0\H<,XSQCE7$2V?,]?O-20;BK\JM-Y W$KNJ0OU*?4L[JI$5
MK=94_)'9A;P^"()76L!Z5]>];0>);;^-@06Z;V;+20F+9&NE%@UY]_\ J2'T
MDRJ4R>;)*))R1(RTBRR4H,M+(24C%%E26I/\./BCAVM^?\@QRO6>1^3VKUQ$
M;ZH;WUM2UO\ ';] WHB[^,7A=+;=ZXM;YK/%=882^P^Y9_-WD3D]^:?#IX]?
MX1H$5*K?P>R*DOV*U_PUO7-29J_AE250NM4K&:1<F3?,M4E5:Q//XQG_ #_Y
MC^_.N,YQSDS_ (?& B=^=GN]/;K:##$]NL.RP2(@J50DHZK.;@G-C3-R.!;)
MPM4>44W68ZM1Y(J6'8^#9F(5A: ) @959?08_+KO[_K^?YXSJ[F(B)L$3)P,
M]& 34'-QYD3,0\J(Q(1DK%R([@DA'2()3;HQH)HKSHQ8I#3C!##KC3J%MK4G
M-&,Y _&9J-H'O3Y9_'Y1+//5K4%BHVY8BNR\'+R0\C1IVA;7 I6N)B/DPRF2
MV;!4 KZ>VX4V^V_(%02$EX<::RTCT+W$2_/[_E_+]O?&3Y\$'92[O:L[*]6>
MQMIE7=K]1MFV-V=/N\\9)R@5,D3)8:>&,EIDA\PL6FW>LVQ1QSS^60X^>A6,
M):8PS\Z2CWB8^DQ[?]8S O$19MH]R.U/>+OY;;=>G-3.62?UGHVE2%CG?VF
M@U(9V'QZXLU,0-,TW6\71HITAH)*2#+G,EY;;,QE:1=1$1U[]=S^O[??\L9J
M7PG;,V/</'-Y!Y^V[ N]HG8)K868.:L5KGIN6ALL:+?-8S%24F>49'99,Q@M
MK(CS/TR<8?1Z=Q\^2<1$^T=>W]YQD8_&3TR[/^2KJO;'ME=W-Q:YTI3=K6:%
MJM7A#Y>SSEMV"_6*?(SM@N<G*6>/(D*U QY5<!KD 208R@U^R$QN:\^^:7-R
M4P,^T1^O[?M^GZ_ZXR4GB'M'8D+=7?SQ:[BW):;;%Z]HFQ(NEW]Z5E):6HIH
M%@9UC(S='+E3W):-B9L2Y0=NC*\](I'A9.+PX%]B9(2[Y<%$=041UW]?W^^\
M97ATP\<TYO#R!]UNN8G:W<VNCM%R%Q&+VM5GRT7/8^879 ]84[:G&K("\M<@
MXY^L%?5DC_9R$YSE:OZN)DO89ZCW[_+Z?M^^,LU\HTQL+3?=?PY:JKFT;]B(
M$M.K:9:2!;--Q";\U";9U+7")*VQX,G@67(F14$KD&Y')R7,'%,...MNN97
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M09U&G;<6%Q5RO=MUG7SU:'NMZ384HL7Q%;*MI;/6^-CU#M?*'"O)/CB]0YY
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MEMH94L*]S>'AGQ8KGEVUN=V\*O$]"T9V4RX4MO/%<6)IPSU#-6J">FWKA$!
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7C'&,<8QQC'&,<8QQC'&,<8QQC'&,_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
